Gene Symbol | Gene ID | Gene Info |
---|---|---|
NRF1
|
ENSG00000106459.10 | nuclear respiratory factor 1 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr7_129214438_129214733 | NRF1 | 36970 | 0.159753 | -0.72 | 2.8e-02 | Click! |
chr7_129283603_129283833 | NRF1 | 13473 | 0.226435 | -0.70 | 3.7e-02 | Click! |
chr7_129252182_129253092 | NRF1 | 1040 | 0.611378 | 0.66 | 5.1e-02 | Click! |
chr7_129257166_129257379 | NRF1 | 5675 | 0.259725 | 0.64 | 6.2e-02 | Click! |
chr7_129304576_129304727 | NRF1 | 7460 | 0.235823 | -0.62 | 7.3e-02 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr2_3522701_3522852 | 3.17 |
AC142528.1 |
|
270 |
0.77 |
chr22_24199875_24200057 | 2.86 |
SLC2A11 |
solute carrier family 2 (facilitated glucose transporter), member 11 |
184 |
0.81 |
chr20_35580060_35580211 | 2.74 |
SAMHD1 |
SAM domain and HD domain 1 |
24 |
0.98 |
chr16_2390815_2390992 | 2.56 |
ABCA3 |
ATP-binding cassette, sub-family A (ABC1), member 3 |
156 |
0.92 |
chr22_42095231_42095503 | 2.53 |
MEI1 |
meiosis inhibitor 1 |
136 |
0.92 |
chr6_31125997_31126148 | 2.33 |
CCHCR1 |
coiled-coil alpha-helical rod protein 1 |
57 |
0.73 |
chr19_49588476_49588627 | 2.32 |
SNRNP70 |
small nuclear ribonucleoprotein 70kDa (U1) |
129 |
0.88 |
chr19_47363571_47364036 | 2.16 |
AP2S1 |
adaptor-related protein complex 2, sigma 1 subunit |
9554 |
0.17 |
chr19_1383420_1383571 | 2.06 |
NDUFS7 |
NADH dehydrogenase (ubiquinone) Fe-S protein 7, 20kDa (NADH-coenzyme Q reductase) |
31 |
0.94 |
chr21_45209121_45209272 | 1.99 |
RRP1 |
ribosomal RNA processing 1 |
198 |
0.93 |
chr2_61372190_61372383 | 1.99 |
C2orf74 |
chromosome 2 open reading frame 74 |
43 |
0.98 |
chr13_95253751_95253983 | 1.96 |
GPR180 |
G protein-coupled receptor 180 |
290 |
0.91 |
chr20_34042583_34042833 | 1.95 |
GDF5 |
growth differentiation factor 5 |
140 |
0.64 |
chr19_56915357_56915660 | 1.94 |
ZNF583 |
zinc finger protein 583 |
125 |
0.92 |
chr19_48867207_48867576 | 1.88 |
TMEM143 |
transmembrane protein 143 |
75 |
0.73 |
chr5_169010500_169010651 | 1.86 |
SPDL1 |
spindle apparatus coiled-coil protein 1 |
63 |
0.98 |
chr19_36618863_36619073 | 1.85 |
CAPNS1 |
calpain, small subunit 1 |
11509 |
0.09 |
chr12_122230893_122231238 | 1.82 |
RHOF |
ras homolog family member F (in filopodia) |
201 |
0.93 |
chr18_10525775_10525964 | 1.76 |
NAPG |
N-ethylmaleimide-sensitive factor attachment protein, gamma |
157 |
0.97 |
chr17_36452726_36452901 | 1.72 |
MRPL45 |
mitochondrial ribosomal protein L45 |
176 |
0.94 |
chr19_50861631_50862161 | 1.72 |
NAPSA |
napsin A aspartic peptidase |
6986 |
0.09 |
chr19_49217598_49217896 | 1.71 |
MAMSTR |
MEF2 activating motif and SAP domain containing transcriptional regulator |
2353 |
0.14 |
chrX_54835286_54835437 | 1.70 |
MAGED2 |
melanoma antigen family D, 2 |
132 |
0.96 |
chr15_73075798_73075989 | 1.69 |
ADPGK |
ADP-dependent glucokinase |
71 |
0.93 |
chr1_29101467_29102340 | 1.64 |
OPRD1 |
opioid receptor, delta 1 |
36751 |
0.12 |
chr11_65101112_65101263 | 1.64 |
DPF2 |
D4, zinc and double PHD fingers family 2 |
38 |
0.96 |
chr16_86588845_86588996 | 1.60 |
MTHFSD |
methenyltetrahydrofolate synthetase domain containing |
79 |
0.97 |
chr17_9479599_9480043 | 1.60 |
STX8 |
syntaxin 8 |
87 |
0.54 |
chr12_54070156_54070478 | 1.56 |
ATP5G2 |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit C2 (subunit 9) |
135 |
0.95 |
chr6_41040285_41040436 | 1.53 |
OARD1 |
O-acyl-ADP-ribose deacylase 1 |
7 |
0.82 |
chr19_11266572_11266789 | 1.51 |
SPC24 |
SPC24, NDC80 kinetochore complex component |
196 |
0.92 |
chrX_17754862_17755280 | 1.51 |
SCML1 |
sex comb on midleg-like 1 (Drosophila) |
517 |
0.86 |
chr15_63340381_63340577 | 1.51 |
TPM1 |
tropomyosin 1 (alpha) |
86 |
0.94 |
chr16_30381739_30381890 | 1.49 |
TBC1D10B |
TBC1 domain family, member 10B |
229 |
0.65 |
chr11_64546452_64546665 | 1.49 |
SF1 |
splicing factor 1 |
300 |
0.83 |
chr20_3996304_3996483 | 1.49 |
RNF24 |
ring finger protein 24 |
164 |
0.96 |
chr9_140118033_140118193 | 1.49 |
C9orf169 |
chromosome 9 open reading frame 169 |
974 |
0.23 |
chr22_37172543_37172980 | 1.49 |
IFT27 |
intraflagellar transport 27 homolog (Chlamydomonas) |
564 |
0.72 |
chr1_243418604_243419136 | 1.48 |
CEP170 |
centrosomal protein 170kDa |
220 |
0.72 |
chr13_28712229_28712485 | 1.47 |
PAN3-AS1 |
PAN3 antisense RNA 1 |
27 |
0.8 |
chr2_113012718_113012869 | 1.45 |
ZC3H8 |
zinc finger CCCH-type containing 8 |
105 |
0.97 |
chr17_76254452_76254830 | 1.44 |
TMEM235 |
transmembrane protein 235 |
26519 |
0.12 |
chr5_52095855_52096006 | 1.43 |
CTD-2288O8.1 |
|
12070 |
0.19 |
chr16_57334462_57334613 | 1.42 |
PLLP |
plasmolipin |
15938 |
0.14 |
chr2_136634130_136634399 | 1.42 |
MCM6 |
minichromosome maintenance complex component 6 |
268 |
0.91 |
chr17_60005390_60005541 | 1.42 |
INTS2 |
integrator complex subunit 2 |
88 |
0.97 |
chr15_34330832_34331086 | 1.41 |
AVEN |
apoptosis, caspase activation inhibitor |
418 |
0.84 |
chr1_16939998_16940149 | 1.40 |
NBPF1 |
neuroblastoma breakpoint family, member 1 |
91 |
0.96 |
chr1_184723746_184723985 | 1.39 |
EDEM3 |
ER degradation enhancer, mannosidase alpha-like 3 |
164 |
0.96 |
chr20_61274054_61274358 | 1.39 |
SLCO4A1 |
solute carrier organic anion transporter family, member 4A1 |
409 |
0.47 |
chr10_104263741_104263944 | 1.38 |
SUFU |
suppressor of fused homolog (Drosophila) |
6 |
0.95 |
chr1_228075645_228075796 | 1.38 |
ENSG00000264483 |
. |
53664 |
0.11 |
chr6_121655397_121655673 | 1.37 |
TBC1D32 |
TBC1 domain family, member 32 |
41 |
0.98 |
chr22_19419389_19419821 | 1.32 |
MRPL40 |
mitochondrial ribosomal protein L40 |
180 |
0.67 |
chr17_36003454_36003605 | 1.31 |
DDX52 |
DEAD (Asp-Glu-Ala-Asp) box polypeptide 52 |
36 |
0.53 |
chr11_64739573_64739789 | 1.31 |
C11orf85 |
chromosome 11 open reading frame 85 |
124 |
0.92 |
chr12_54674066_54674261 | 1.30 |
HNRNPA1 |
heterogeneous nuclear ribonucleoprotein A1 |
186 |
0.58 |
chr19_19496596_19496747 | 1.30 |
GATAD2A |
GATA zinc finger domain containing 2A |
29 |
0.97 |
chr5_150460010_150460252 | 1.29 |
TNIP1 |
TNFAIP3 interacting protein 1 |
446 |
0.84 |
chr3_4910344_4910625 | 1.29 |
ENSG00000239126 |
. |
9902 |
0.2 |
chr14_78108377_78108627 | 1.28 |
SPTLC2 |
serine palmitoyltransferase, long chain base subunit 2 |
25386 |
0.16 |
chr17_4736385_4736546 | 1.27 |
MINK1 |
misshapen-like kinase 1 |
218 |
0.86 |
chr19_2427673_2427902 | 1.26 |
TIMM13 |
translocase of inner mitochondrial membrane 13 homolog (yeast) |
105 |
0.95 |
chr11_118271970_118272245 | 1.25 |
ATP5L |
ATP synthase, H+ transporting, mitochondrial Fo complex, subunit G |
238 |
0.69 |
chr16_279128_279418 | 1.25 |
LUC7L |
LUC7-like (S. cerevisiae) |
148 |
0.91 |
chr11_60609237_60609428 | 1.25 |
CCDC86 |
coiled-coil domain containing 86 |
212 |
0.83 |
chr19_16222015_16222208 | 1.24 |
RAB8A |
RAB8A, member RAS oncogene family |
328 |
0.84 |
chr19_46234272_46234446 | 1.24 |
FBXO46 |
F-box protein 46 |
197 |
0.85 |
chr5_217753_218381 | 1.24 |
CCDC127 |
coiled-coil domain containing 127 |
263 |
0.5 |
chr15_44116988_44117284 | 1.23 |
MFAP1 |
microfibrillar-associated protein 1 |
136 |
0.91 |
chr17_43298346_43298590 | 1.23 |
CTD-2020K17.1 |
|
664 |
0.36 |
chr7_99869720_99870133 | 1.22 |
GATS |
GATS, stromal antigen 3 opposite strand |
71 |
0.95 |
chr19_50432810_50433196 | 1.22 |
NUP62 |
nucleoporin 62kDa |
2 |
0.66 |
chr8_117887202_117887456 | 1.22 |
RAD21 |
RAD21 homolog (S. pombe) |
224 |
0.52 |
chrX_47517975_47518127 | 1.21 |
UXT-AS1 |
UXT antisense RNA 1 |
181 |
0.76 |
chr17_45570068_45570247 | 1.21 |
MRPL45P2 |
mitochondrial ribosomal protein L45 pseudogene 2 |
332 |
0.88 |
chr19_5827971_5828196 | 1.20 |
NRTN |
neurturin |
4270 |
0.1 |
chr2_232526625_232527001 | 1.20 |
ENSG00000239202 |
. |
15829 |
0.16 |
chr2_20550724_20551509 | 1.20 |
PUM2 |
pumilio RNA-binding family member 2 |
653 |
0.67 |
chr15_78832765_78833017 | 1.19 |
PSMA4 |
proteasome (prosome, macropain) subunit, alpha type, 4 |
71 |
0.95 |
chr1_150336049_150336200 | 1.19 |
RPRD2 |
regulation of nuclear pre-mRNA domain containing 2 |
1002 |
0.47 |
chr21_30256992_30257908 | 1.19 |
N6AMT1 |
N-6 adenine-specific DNA methyltransferase 1 (putative) |
243 |
0.95 |
chr9_100459687_100459908 | 1.18 |
XPA |
xeroderma pigmentosum, complementation group A |
158 |
0.94 |
chr5_70196258_70196507 | 1.18 |
SERF1A |
small EDRK-rich factor 1A (telomeric) |
110 |
0.97 |
chr2_3522990_3523243 | 1.18 |
AC142528.1 |
|
70 |
0.84 |
chr10_43951098_43951286 | 1.18 |
ENSG00000252532 |
. |
2321 |
0.26 |
chr7_5821069_5821360 | 1.17 |
RNF216 |
ring finger protein 216 |
37 |
0.98 |
chr19_56116555_56116820 | 1.17 |
ZNF865 |
zinc finger protein 865 |
84 |
0.91 |
chr2_197791498_197791649 | 1.17 |
PGAP1 |
post-GPI attachment to proteins 1 |
104 |
0.98 |
chr22_18257315_18257654 | 1.16 |
BID |
BH3 interacting domain death agonist |
53 |
0.97 |
chr7_158936828_158937151 | 1.16 |
VIPR2 |
vasoactive intestinal peptide receptor 2 |
555 |
0.87 |
chr21_43640506_43640792 | 1.14 |
ENSG00000223262 |
. |
634 |
0.47 |
chr1_213189220_213189371 | 1.14 |
ANGEL2 |
angel homolog 2 (Drosophila) |
127 |
0.97 |
chr7_100861322_100861626 | 1.13 |
PLOD3 |
procollagen-lysine, 2-oxoglutarate 5-dioxygenase 3 |
199 |
0.75 |
chrX_24711721_24711887 | 1.13 |
POLA1 |
polymerase (DNA directed), alpha 1, catalytic subunit |
232 |
0.92 |
chr14_69094821_69095326 | 1.13 |
CTD-2325P2.4 |
|
89 |
0.98 |
chr1_29507945_29508271 | 1.13 |
SRSF4 |
serine/arginine-rich splicing factor 4 |
302 |
0.88 |
chr3_31573575_31573846 | 1.13 |
STT3B |
STT3B, subunit of the oligosaccharyltransferase complex (catalytic) |
572 |
0.85 |
chr22_50353929_50354264 | 1.12 |
PIM3 |
pim-3 oncogene |
65 |
0.97 |
chr17_7137454_7137768 | 1.11 |
DVL2 |
dishevelled segment polarity protein 2 |
16 |
0.92 |
chr2_220042618_220042887 | 1.11 |
CNPPD1 |
cyclin Pas1/PHO80 domain containing 1 |
76 |
0.53 |
chr11_60681392_60681594 | 1.11 |
RP11-881M11.1 |
|
31 |
0.63 |
chr9_139685367_139685521 | 1.11 |
TMEM141 |
transmembrane protein 141 |
363 |
0.42 |
chr14_39643931_39644138 | 1.10 |
PNN |
pinin, desmosome associated protein |
353 |
0.85 |
chr21_40751925_40752262 | 1.10 |
WRB |
tryptophan rich basic protein |
77 |
0.96 |
chr16_30759639_30759938 | 1.10 |
PHKG2 |
phosphorylase kinase, gamma 2 (testis) |
27 |
0.95 |
chr12_48499913_48500348 | 1.10 |
SENP1 |
SUMO1/sentrin specific peptidase 1 |
39 |
0.49 |
chr1_154976041_154976288 | 1.09 |
ZBTB7B |
zinc finger and BTB domain containing 7B |
869 |
0.33 |
chr17_17942741_17942956 | 1.08 |
GID4 |
GID complex subunit 4 |
89 |
0.78 |
chr3_47555010_47555200 | 1.08 |
ELP6 |
elongator acetyltransferase complex subunit 6 |
146 |
0.94 |
chr1_108508002_108508614 | 1.08 |
VAV3 |
vav 3 guanine nucleotide exchange factor |
542 |
0.7 |
chr19_10676489_10676661 | 1.08 |
KRI1 |
KRI1 homolog (S. cerevisiae) |
91 |
0.93 |
chr11_18656105_18656627 | 1.07 |
SPTY2D1 |
SPT2, Suppressor of Ty, domain containing 1 (S. cerevisiae) |
326 |
0.87 |
chr6_26123823_26124055 | 1.06 |
HIST1H2BC |
histone cluster 1, H2bc |
199 |
0.68 |
chr17_44344409_44344766 | 1.06 |
RP11-259G18.1 |
|
191 |
0.93 |
chr19_50887623_50887879 | 1.06 |
POLD1 |
polymerase (DNA directed), delta 1, catalytic subunit |
121 |
0.91 |
chr5_81574185_81574688 | 1.06 |
RPS23 |
ribosomal protein S23 |
40 |
0.95 |
chr14_50319523_50319960 | 1.05 |
NEMF |
nuclear export mediator factor |
180 |
0.85 |
chr17_7518574_7518865 | 1.05 |
FXR2 |
fragile X mental retardation, autosomal homolog 2 |
530 |
0.41 |
chr1_149821944_149822390 | 1.05 |
HIST2H2AA4 |
histone cluster 2, H2aa4 |
476 |
0.5 |
chr13_95201650_95201933 | 1.04 |
TGDS |
TDP-glucose 4,6-dehydratase |
46720 |
0.13 |
chr7_75796010_75796256 | 1.04 |
AC005077.5 |
|
6918 |
0.18 |
chr6_153304524_153304798 | 1.04 |
FBXO5 |
F-box protein 5 |
53 |
0.73 |
chr16_2265076_2265283 | 1.04 |
PGP |
phosphoglycolate phosphatase |
371 |
0.61 |
chr4_178231041_178231773 | 1.04 |
NEIL3 |
nei endonuclease VIII-like 3 (E. coli) |
417 |
0.87 |
chr4_184642511_184642662 | 1.04 |
ENSG00000251739 |
. |
15502 |
0.17 |
chr19_17416354_17416505 | 1.04 |
MRPL34 |
mitochondrial ribosomal protein L34 |
48 |
0.92 |
chr5_64331070_64331877 | 1.04 |
ENSG00000207439 |
. |
87723 |
0.1 |
chr20_18447768_18448009 | 1.04 |
DZANK1 |
double zinc ribbon and ankyrin repeat domains 1 |
59 |
0.57 |
chr18_158238_158410 | 1.04 |
USP14 |
ubiquitin specific peptidase 14 (tRNA-guanine transglycosylase) |
59 |
0.98 |
chr19_18058936_18059258 | 1.03 |
KCNN1 |
potassium intermediate/small conductance calcium-activated channel, subfamily N, member 1 |
3005 |
0.18 |
chr21_47648763_47648914 | 1.03 |
LSS |
lanosterol synthase (2,3-oxidosqualene-lanosterol cyclase) |
100 |
0.73 |
chr18_20513344_20513796 | 1.03 |
RP11-739L10.1 |
|
157 |
0.44 |
chr17_27467519_27468040 | 1.03 |
RP11-321A17.4 |
|
278 |
0.55 |
chrX_47880068_47880219 | 1.03 |
SPACA5 |
sperm acrosome associated 5 |
12949 |
0.14 |
chr3_52188946_52189141 | 1.03 |
POC1A |
POC1 centriolar protein A |
337 |
0.85 |
chrX_133940887_133941194 | 1.02 |
FAM122C |
family with sequence similarity 122C |
183 |
0.94 |
chr16_31085838_31086052 | 1.02 |
ZNF646 |
zinc finger protein 646 |
181 |
0.6 |
chr5_162887153_162887344 | 1.02 |
HMMR |
hyaluronan-mediated motility receptor (RHAMM) |
39 |
0.57 |
chr12_112546663_112546943 | 1.01 |
NAA25 |
N(alpha)-acetyltransferase 25, NatB auxiliary subunit |
23 |
0.97 |
chr1_40349190_40349341 | 1.00 |
TRIT1 |
tRNA isopentenyltransferase 1 |
87 |
0.95 |
chr5_10250450_10250920 | 1.00 |
CCT5 |
chaperonin containing TCP1, subunit 5 (epsilon) |
34 |
0.92 |
chr8_11626901_11627115 | 0.99 |
NEIL2 |
nei endonuclease VIII-like 2 (E. coli) |
140 |
0.94 |
chr17_71188538_71188928 | 0.99 |
COG1 |
component of oligomeric golgi complex 1 |
396 |
0.83 |
chrX_7066413_7066788 | 0.99 |
HDHD1 |
haloacid dehalogenase-like hydrolase domain containing 1 |
369 |
0.71 |
chr5_138678038_138678710 | 0.99 |
PAIP2 |
poly(A) binding protein interacting protein 2 |
234 |
0.87 |
chr4_2043674_2043888 | 0.98 |
C4orf48 |
chromosome 4 open reading frame 48 |
4 |
0.66 |
chr12_69753428_69753934 | 0.98 |
YEATS4 |
YEATS domain containing 4 |
122 |
0.96 |
chr5_128430184_128430335 | 0.98 |
ISOC1 |
isochorismatase domain containing 1 |
185 |
0.96 |
chr3_143690649_143690852 | 0.98 |
C3orf58 |
chromosome 3 open reading frame 58 |
110 |
0.98 |
chr9_131843419_131843919 | 0.98 |
DOLPP1 |
dolichyldiphosphatase 1 |
256 |
0.86 |
chr1_33430206_33430511 | 0.98 |
RNF19B |
ring finger protein 19B |
72 |
0.96 |
chr13_34184631_34184800 | 0.98 |
RFC3 |
replication factor C (activator 1) 3, 38kDa |
207471 |
0.02 |
chr16_8715324_8715502 | 0.97 |
METTL22 |
methyltransferase like 22 |
127 |
0.97 |
chr17_38279440_38280347 | 0.97 |
MSL1 |
male-specific lethal 1 homolog (Drosophila) |
937 |
0.43 |
chr7_149275_149447 | 0.97 |
FAM20C |
family with sequence similarity 20, member C |
43608 |
0.16 |
chr6_33679104_33679457 | 0.97 |
UQCC2 |
ubiquinol-cytochrome c reductase complex assembly factor 2 |
181 |
0.93 |
chr1_234614585_234614936 | 0.97 |
TARBP1 |
TAR (HIV-1) RNA binding protein 1 |
89 |
0.98 |
chr21_38630680_38631091 | 0.97 |
DSCR3 |
Down syndrome critical region gene 3 |
8738 |
0.17 |
chr6_157542417_157542568 | 0.97 |
ARID1B |
AT rich interactive domain 1B (SWI1-like) |
72447 |
0.12 |
chr2_157189525_157189762 | 0.97 |
NR4A2 |
nuclear receptor subfamily 4, group A, member 2 |
411 |
0.9 |
chr22_31318038_31318328 | 0.96 |
MORC2-AS1 |
MORC2 antisense RNA 1 |
112 |
0.96 |
chr5_8457675_8458050 | 0.96 |
ENSG00000247516 |
. |
3176 |
0.41 |
chr16_10837539_10837690 | 0.96 |
NUBP1 |
nucleotide binding protein 1 |
29 |
0.98 |
chr1_59012277_59012442 | 0.96 |
OMA1 |
OMA1 zinc metallopeptidase |
19 |
0.98 |
chr17_33307453_33307681 | 0.95 |
LIG3 |
ligase III, DNA, ATP-dependent |
2 |
0.9 |
chr10_45374254_45374405 | 0.95 |
TMEM72 |
transmembrane protein 72 |
32319 |
0.15 |
chr7_138915956_138916227 | 0.95 |
UBN2 |
ubinuclein 2 |
140 |
0.97 |
chr4_57844753_57845118 | 0.95 |
NOA1 |
nitric oxide associated 1 |
54 |
0.54 |
chr12_74931255_74931613 | 0.94 |
ATXN7L3B |
ataxin 7-like 3B |
117 |
0.94 |
chr1_206785946_206786193 | 0.94 |
EIF2D |
eukaryotic translation initiation factor 2D |
165 |
0.94 |
chr9_129567018_129567215 | 0.94 |
ZBTB43 |
zinc finger and BTB domain containing 43 |
169 |
0.96 |
chr1_149814537_149814930 | 0.93 |
HIST2H2AA3 |
histone cluster 2, H2aa3 |
255 |
0.75 |
chr10_104262463_104262753 | 0.93 |
ACTR1A |
ARP1 actin-related protein 1 homolog A, centractin alpha (yeast) |
126 |
0.91 |
chr10_70231482_70231737 | 0.93 |
DNA2 |
DNA replication helicase/nuclease 2 |
34 |
0.97 |
chr2_128568808_128569035 | 0.93 |
WDR33 |
WD repeat domain 33 |
160 |
0.94 |
chr6_135502328_135502497 | 0.92 |
MYB |
v-myb avian myeloblastosis viral oncogene homolog |
41 |
0.98 |
chr12_107349405_107349556 | 0.92 |
C12orf23 |
chromosome 12 open reading frame 23 |
17 |
0.73 |
chr12_95397551_95397813 | 0.92 |
NDUFA12 |
NADH dehydrogenase (ubiquinone) 1 alpha subcomplex, 12 |
136 |
0.97 |
chr13_49105975_49106823 | 0.92 |
RCBTB2 |
regulator of chromosome condensation (RCC1) and BTB (POZ) domain containing protein 2 |
814 |
0.75 |
chr7_6487670_6487879 | 0.92 |
DAGLB |
diacylglycerol lipase, beta |
131 |
0.96 |
chr18_12883567_12883875 | 0.92 |
PTPN2 |
protein tyrosine phosphatase, non-receptor type 2 |
492 |
0.84 |
chr1_246670647_246670813 | 0.91 |
SMYD3 |
SET and MYND domain containing 3 |
116 |
0.97 |
chr12_133613669_133614058 | 0.91 |
ZNF84 |
zinc finger protein 84 |
15 |
0.97 |
chr6_143999142_144000093 | 0.91 |
PHACTR2 |
phosphatase and actin regulator 2 |
412 |
0.9 |
chr3_135915266_135915783 | 0.91 |
MSL2 |
male-specific lethal 2 homolog (Drosophila) |
93 |
0.98 |
chr19_10305607_10305758 | 0.90 |
DNMT1 |
DNA (cytosine-5-)-methyltransferase 1 |
73 |
0.95 |
chr3_44379324_44379833 | 0.90 |
TCAIM |
T cell activation inhibitor, mitochondrial |
33 |
0.89 |
chr21_37692001_37692354 | 0.90 |
MORC3 |
MORC family CW-type zinc finger 3 |
310 |
0.75 |
chr6_27806407_27806618 | 0.90 |
HIST1H2BN |
histone cluster 1, H2bn |
72 |
0.8 |
chr5_75699014_75699893 | 0.89 |
IQGAP2 |
IQ motif containing GTPase activating protein 2 |
304 |
0.94 |
chr22_24236955_24237160 | 0.89 |
MIF |
macrophage migration inhibitory factor (glycosylation-inhibiting factor) |
866 |
0.41 |
chr19_11616618_11616769 | 0.89 |
ZNF653 |
zinc finger protein 653 |
45 |
0.95 |
chr2_64554540_64554897 | 0.89 |
ENSG00000264297 |
. |
13175 |
0.25 |
chr22_42062744_42062895 | 0.88 |
ENSG00000207457 |
. |
12896 |
0.1 |
chr14_21852624_21852819 | 0.88 |
RP11-524O1.4 |
|
270 |
0.49 |
chr1_8939232_8939383 | 0.88 |
ENO1 |
enolase 1, (alpha) |
1 |
0.86 |
chr1_73101671_73101822 | 0.88 |
ENSG00000212366 |
. |
81706 |
0.12 |
chr19_40791502_40791751 | 0.87 |
AKT2 |
v-akt murine thymoma viral oncogene homolog 2 |
183 |
0.89 |
chr6_27114265_27114575 | 0.87 |
HIST1H2BK |
histone cluster 1, H2bk |
157 |
0.74 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 3.0 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.5 | 2.0 | GO:0060218 | hematopoietic stem cell differentiation(GO:0060218) |
0.4 | 2.1 | GO:0043984 | histone H4-K16 acetylation(GO:0043984) |
0.4 | 1.2 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
0.4 | 1.2 | GO:0001996 | positive regulation of heart rate by epinephrine-norepinephrine(GO:0001996) |
0.4 | 1.1 | GO:0044340 | canonical Wnt signaling pathway involved in regulation of cell proliferation(GO:0044340) |
0.3 | 0.6 | GO:0019372 | lipoxygenase pathway(GO:0019372) |
0.3 | 1.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
0.3 | 0.5 | GO:0002025 | vasodilation by norepinephrine-epinephrine involved in regulation of systemic arterial blood pressure(GO:0002025) |
0.3 | 0.8 | GO:0019509 | L-methionine biosynthetic process from methylthioadenosine(GO:0019509) |
0.3 | 0.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
0.3 | 1.3 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.3 | 0.8 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.2 | 0.2 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.2 | 0.7 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
0.2 | 1.0 | GO:0010748 | negative regulation of plasma membrane long-chain fatty acid transport(GO:0010748) negative regulation of anion transmembrane transport(GO:1903960) negative regulation of fatty acid transport(GO:2000192) |
0.2 | 0.7 | GO:0002540 | arachidonic acid metabolite production involved in inflammatory response(GO:0002538) leukotriene production involved in inflammatory response(GO:0002540) |
0.2 | 0.7 | GO:0070050 | neuron cellular homeostasis(GO:0070050) |
0.2 | 0.9 | GO:0072386 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
0.2 | 2.3 | GO:0097031 | NADH dehydrogenase complex assembly(GO:0010257) mitochondrial respiratory chain complex I assembly(GO:0032981) mitochondrial respiratory chain complex I biogenesis(GO:0097031) |
0.2 | 0.7 | GO:0045990 | carbon catabolite regulation of transcription(GO:0045990) regulation of transcription by glucose(GO:0046015) |
0.2 | 1.3 | GO:0032464 | positive regulation of protein homooligomerization(GO:0032464) |
0.2 | 2.2 | GO:0007141 | male meiosis I(GO:0007141) |
0.2 | 0.9 | GO:0042416 | dopamine biosynthetic process(GO:0042416) |
0.2 | 0.9 | GO:0010457 | centriole-centriole cohesion(GO:0010457) |
0.2 | 0.6 | GO:0006065 | UDP-glucuronate biosynthetic process(GO:0006065) |
0.2 | 0.6 | GO:0019886 | antigen processing and presentation of exogenous peptide antigen via MHC class II(GO:0019886) |
0.2 | 1.0 | GO:0016188 | synaptic vesicle maturation(GO:0016188) |
0.2 | 1.5 | GO:0033085 | negative regulation of T cell differentiation in thymus(GO:0033085) negative regulation of thymocyte aggregation(GO:2000399) |
0.2 | 1.0 | GO:0030388 | fructose 1,6-bisphosphate metabolic process(GO:0030388) |
0.2 | 0.8 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
0.2 | 1.6 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.2 | 0.8 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.2 | 1.4 | GO:0015851 | nucleobase transport(GO:0015851) |
0.2 | 1.4 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
0.2 | 0.8 | GO:0045945 | positive regulation of transcription from RNA polymerase III promoter(GO:0045945) |
0.2 | 1.0 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.2 | 0.6 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
0.2 | 1.1 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.2 | 3.2 | GO:0015986 | energy coupled proton transport, down electrochemical gradient(GO:0015985) ATP synthesis coupled proton transport(GO:0015986) |
0.2 | 0.5 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
0.2 | 0.5 | GO:0005997 | xylulose metabolic process(GO:0005997) |
0.2 | 0.5 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
0.2 | 1.0 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
0.2 | 0.5 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
0.2 | 1.0 | GO:0048261 | negative regulation of receptor-mediated endocytosis(GO:0048261) |
0.2 | 0.5 | GO:0008215 | spermine metabolic process(GO:0008215) |
0.2 | 0.6 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.2 | 0.9 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
0.1 | 1.2 | GO:0009886 | post-embryonic morphogenesis(GO:0009886) |
0.1 | 0.6 | GO:0019255 | glucose 1-phosphate metabolic process(GO:0019255) |
0.1 | 1.2 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.1 | 1.0 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
0.1 | 0.7 | GO:0008356 | asymmetric cell division(GO:0008356) |
0.1 | 1.4 | GO:0045843 | negative regulation of striated muscle tissue development(GO:0045843) |
0.1 | 0.3 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.1 | 0.6 | GO:0051409 | response to nitrosative stress(GO:0051409) |
0.1 | 0.6 | GO:0016266 | O-glycan processing(GO:0016266) |
0.1 | 2.0 | GO:0006906 | vesicle fusion(GO:0006906) |
0.1 | 0.4 | GO:0070669 | response to interleukin-2(GO:0070669) |
0.1 | 0.1 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
0.1 | 0.8 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.1 | 0.5 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.1 | 0.9 | GO:0006105 | succinate metabolic process(GO:0006105) |
0.1 | 0.7 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
0.1 | 2.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.1 | 0.4 | GO:0097501 | detoxification of inorganic compound(GO:0061687) stress response to metal ion(GO:0097501) |
0.1 | 0.6 | GO:0009249 | protein lipoylation(GO:0009249) |
0.1 | 1.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.1 | 1.5 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.5 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
0.1 | 0.3 | GO:1900121 | regulation of receptor binding(GO:1900120) negative regulation of receptor binding(GO:1900121) |
0.1 | 1.0 | GO:0015791 | polyol transport(GO:0015791) |
0.1 | 1.1 | GO:0006268 | DNA unwinding involved in DNA replication(GO:0006268) |
0.1 | 1.9 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.1 | 0.5 | GO:0060539 | diaphragm development(GO:0060539) |
0.1 | 0.2 | GO:0071504 | cellular response to heparin(GO:0071504) |
0.1 | 0.2 | GO:0006573 | valine metabolic process(GO:0006573) |
0.1 | 0.6 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
0.1 | 0.6 | GO:0060742 | epithelial cell differentiation involved in prostate gland development(GO:0060742) |
0.1 | 0.1 | GO:0003339 | regulation of mesenchymal to epithelial transition involved in metanephros morphogenesis(GO:0003339) |
0.1 | 0.4 | GO:0010508 | positive regulation of autophagy(GO:0010508) |
0.1 | 0.5 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.1 | 0.2 | GO:0007028 | cytoplasm organization(GO:0007028) |
0.1 | 1.3 | GO:0050812 | acetyl-CoA biosynthetic process from pyruvate(GO:0006086) regulation of acetyl-CoA biosynthetic process from pyruvate(GO:0010510) regulation of acyl-CoA biosynthetic process(GO:0050812) |
0.1 | 0.4 | GO:0009051 | pentose-phosphate shunt, oxidative branch(GO:0009051) |
0.1 | 0.6 | GO:0010887 | negative regulation of cholesterol storage(GO:0010887) |
0.1 | 0.4 | GO:0006000 | fructose metabolic process(GO:0006000) |
0.1 | 0.2 | GO:0043461 | proton-transporting ATP synthase complex assembly(GO:0043461) proton-transporting ATP synthase complex biogenesis(GO:0070272) |
0.1 | 0.3 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.1 | 1.1 | GO:0006301 | postreplication repair(GO:0006301) |
0.1 | 0.2 | GO:0006488 | dolichol-linked oligosaccharide biosynthetic process(GO:0006488) oligosaccharide-lipid intermediate biosynthetic process(GO:0006490) |
0.1 | 0.7 | GO:0043631 | RNA polyadenylation(GO:0043631) |
0.1 | 1.2 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
0.1 | 0.6 | GO:0019042 | viral latency(GO:0019042) |
0.1 | 0.3 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 1.2 | GO:0045947 | negative regulation of translational initiation(GO:0045947) |
0.1 | 0.3 | GO:0048859 | formation of anatomical boundary(GO:0048859) |
0.1 | 0.5 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.1 | 0.3 | GO:0045722 | positive regulation of gluconeogenesis(GO:0045722) |
0.1 | 1.0 | GO:0045879 | negative regulation of smoothened signaling pathway(GO:0045879) |
0.1 | 1.2 | GO:0050691 | regulation of defense response to virus by host(GO:0050691) |
0.1 | 0.2 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
0.1 | 0.3 | GO:0006562 | proline catabolic process(GO:0006562) |
0.1 | 0.2 | GO:0055089 | fatty acid homeostasis(GO:0055089) |
0.1 | 1.0 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
0.1 | 0.3 | GO:0043589 | skin morphogenesis(GO:0043589) |
0.1 | 0.3 | GO:0042996 | regulation of Golgi to plasma membrane protein transport(GO:0042996) |
0.1 | 0.6 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
0.1 | 0.5 | GO:0042891 | tetracycline transport(GO:0015904) antibiotic transport(GO:0042891) toxin transport(GO:1901998) |
0.1 | 0.3 | GO:0045110 | intermediate filament bundle assembly(GO:0045110) |
0.1 | 1.5 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
0.1 | 0.3 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
0.1 | 0.3 | GO:0006530 | asparagine catabolic process(GO:0006530) asparagine catabolic process via L-aspartate(GO:0033345) |
0.1 | 0.4 | GO:0001553 | luteinization(GO:0001553) |
0.1 | 0.7 | GO:0006895 | Golgi to endosome transport(GO:0006895) Golgi to vacuole transport(GO:0006896) |
0.1 | 0.3 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
0.1 | 0.2 | GO:0001661 | conditioned taste aversion(GO:0001661) |
0.1 | 3.3 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.1 | 0.5 | GO:0047497 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
0.1 | 0.2 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.1 | 0.2 | GO:0060136 | embryonic process involved in female pregnancy(GO:0060136) |
0.1 | 0.4 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) negative regulation of signal transduction by p53 class mediator(GO:1901797) |
0.1 | 0.2 | GO:0034625 | fatty acid elongation, monounsaturated fatty acid(GO:0034625) |
0.1 | 0.3 | GO:0003032 | detection of oxygen(GO:0003032) |
0.1 | 0.5 | GO:0031498 | nucleosome disassembly(GO:0006337) chromatin disassembly(GO:0031498) protein-DNA complex disassembly(GO:0032986) |
0.1 | 0.2 | GO:0032000 | positive regulation of fatty acid beta-oxidation(GO:0032000) |
0.1 | 0.1 | GO:0048631 | regulation of skeletal muscle tissue growth(GO:0048631) |
0.1 | 0.9 | GO:0001782 | B cell homeostasis(GO:0001782) |
0.1 | 0.2 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
0.1 | 6.9 | GO:0006334 | nucleosome assembly(GO:0006334) |
0.1 | 0.9 | GO:0006825 | copper ion transport(GO:0006825) |
0.1 | 0.3 | GO:0007171 | activation of transmembrane receptor protein tyrosine kinase activity(GO:0007171) |
0.1 | 0.1 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
0.1 | 0.5 | GO:0007007 | inner mitochondrial membrane organization(GO:0007007) |
0.1 | 0.4 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.1 | 0.4 | GO:0032292 | myelination in peripheral nervous system(GO:0022011) peripheral nervous system axon ensheathment(GO:0032292) |
0.1 | 0.1 | GO:0009106 | lipoate metabolic process(GO:0009106) |
0.1 | 0.4 | GO:0042104 | positive regulation of activated T cell proliferation(GO:0042104) |
0.1 | 0.1 | GO:0051832 | evasion or tolerance of host defenses by virus(GO:0019049) avoidance of host defenses(GO:0044413) evasion or tolerance of host defenses(GO:0044415) avoidance of defenses of other organism involved in symbiotic interaction(GO:0051832) evasion or tolerance of defenses of other organism involved in symbiotic interaction(GO:0051834) |
0.1 | 0.4 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.1 | 0.1 | GO:0032261 | purine nucleotide salvage(GO:0032261) |
0.1 | 0.1 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
0.1 | 0.2 | GO:0007042 | lysosomal lumen acidification(GO:0007042) regulation of lysosomal lumen pH(GO:0035751) |
0.1 | 0.5 | GO:0008535 | respiratory chain complex IV assembly(GO:0008535) |
0.1 | 0.6 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
0.1 | 0.2 | GO:1900078 | positive regulation of insulin receptor signaling pathway(GO:0046628) positive regulation of cellular response to insulin stimulus(GO:1900078) |
0.1 | 1.0 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
0.1 | 0.3 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 0.4 | GO:0034285 | response to sucrose(GO:0009744) response to disaccharide(GO:0034285) |
0.1 | 0.2 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
0.1 | 0.2 | GO:0030187 | melatonin metabolic process(GO:0030186) melatonin biosynthetic process(GO:0030187) |
0.1 | 0.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
0.1 | 1.3 | GO:0005980 | glycogen catabolic process(GO:0005980) |
0.1 | 0.6 | GO:0048636 | positive regulation of striated muscle tissue development(GO:0045844) positive regulation of muscle organ development(GO:0048636) positive regulation of muscle tissue development(GO:1901863) |
0.1 | 0.3 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
0.1 | 0.1 | GO:0002634 | regulation of germinal center formation(GO:0002634) |
0.1 | 0.2 | GO:0031297 | replication fork processing(GO:0031297) |
0.1 | 0.2 | GO:0000731 | DNA synthesis involved in DNA repair(GO:0000731) |
0.1 | 0.3 | GO:0042921 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
0.1 | 0.8 | GO:0050684 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
0.1 | 0.1 | GO:0032927 | positive regulation of activin receptor signaling pathway(GO:0032927) |
0.1 | 1.0 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
0.1 | 0.1 | GO:0061072 | iris morphogenesis(GO:0061072) |
0.1 | 0.1 | GO:1903170 | negative regulation of release of sequestered calcium ion into cytosol(GO:0051280) positive regulation of sequestering of calcium ion(GO:0051284) negative regulation of calcium ion transmembrane transport(GO:1903170) |
0.1 | 1.2 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
0.1 | 0.5 | GO:0072665 | protein targeting to lysosome(GO:0006622) protein targeting to vacuole(GO:0006623) protein localization to lysosome(GO:0061462) protein localization to vacuole(GO:0072665) establishment of protein localization to vacuole(GO:0072666) |
0.1 | 5.3 | GO:0018279 | peptidyl-asparagine modification(GO:0018196) protein N-linked glycosylation via asparagine(GO:0018279) |
0.1 | 1.6 | GO:0006284 | base-excision repair(GO:0006284) |
0.1 | 0.3 | GO:0046498 | S-adenosylhomocysteine metabolic process(GO:0046498) |
0.1 | 0.2 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.1 | 0.2 | GO:0015840 | urea transport(GO:0015840) |
0.1 | 0.2 | GO:0002098 | tRNA wobble base modification(GO:0002097) tRNA wobble uridine modification(GO:0002098) tRNA thio-modification(GO:0034227) |
0.1 | 0.2 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.1 | 0.1 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
0.1 | 0.3 | GO:0006451 | selenocysteine incorporation(GO:0001514) translational readthrough(GO:0006451) |
0.1 | 0.9 | GO:0006312 | mitotic recombination(GO:0006312) |
0.1 | 0.3 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
0.1 | 0.2 | GO:0000244 | spliceosomal tri-snRNP complex assembly(GO:0000244) |
0.1 | 0.1 | GO:0060633 | negative regulation of transcription initiation from RNA polymerase II promoter(GO:0060633) negative regulation of DNA-templated transcription, initiation(GO:2000143) |
0.1 | 0.2 | GO:0032007 | negative regulation of TOR signaling(GO:0032007) |
0.1 | 0.5 | GO:0043508 | negative regulation of JUN kinase activity(GO:0043508) |
0.1 | 0.1 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
0.1 | 0.1 | GO:0002902 | regulation of B cell apoptotic process(GO:0002902) |
0.1 | 0.3 | GO:0032042 | mitochondrial DNA metabolic process(GO:0032042) |
0.1 | 1.4 | GO:0008630 | intrinsic apoptotic signaling pathway in response to DNA damage(GO:0008630) |
0.1 | 0.6 | GO:0043968 | histone H2A acetylation(GO:0043968) |
0.1 | 0.2 | GO:0032212 | positive regulation of telomere maintenance via telomerase(GO:0032212) positive regulation of telomere maintenance via telomere lengthening(GO:1904358) |
0.1 | 0.6 | GO:0007020 | microtubule nucleation(GO:0007020) |
0.1 | 0.2 | GO:0051927 | obsolete negative regulation of calcium ion transport via voltage-gated calcium channel activity(GO:0051927) |
0.1 | 0.1 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) |
0.1 | 0.3 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
0.1 | 0.5 | GO:0006555 | methionine metabolic process(GO:0006555) |
0.1 | 0.1 | GO:0097576 | vacuole fusion(GO:0097576) |
0.1 | 0.7 | GO:0043252 | sodium-independent organic anion transport(GO:0043252) |
0.1 | 2.3 | GO:0006096 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
0.1 | 0.5 | GO:0006743 | ubiquinone metabolic process(GO:0006743) ubiquinone biosynthetic process(GO:0006744) |
0.1 | 2.7 | GO:0051607 | defense response to virus(GO:0051607) |
0.1 | 2.0 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
0.1 | 0.2 | GO:0000492 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
0.1 | 0.4 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.1 | 0.4 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
0.1 | 0.8 | GO:0032006 | regulation of TOR signaling(GO:0032006) |
0.1 | 0.2 | GO:0030970 | retrograde protein transport, ER to cytosol(GO:0030970) |
0.1 | 0.3 | GO:0090004 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
0.1 | 0.2 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
0.0 | 3.3 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
0.0 | 0.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
0.0 | 0.1 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
0.0 | 0.1 | GO:0071731 | response to nitric oxide(GO:0071731) |
0.0 | 0.1 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
0.0 | 0.1 | GO:0034442 | plasma lipoprotein particle oxidation(GO:0034441) regulation of lipoprotein oxidation(GO:0034442) negative regulation of lipoprotein oxidation(GO:0034443) regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) lipoprotein modification(GO:0042160) lipoprotein oxidation(GO:0042161) |
0.0 | 0.1 | GO:0032727 | interferon-alpha production(GO:0032607) regulation of interferon-alpha production(GO:0032647) positive regulation of interferon-alpha production(GO:0032727) |
0.0 | 0.1 | GO:0072239 | metanephric glomerulus development(GO:0072224) metanephric glomerulus vasculature development(GO:0072239) |
0.0 | 0.2 | GO:1902808 | traversing start control point of mitotic cell cycle(GO:0007089) positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) positive regulation of cell cycle G1/S phase transition(GO:1902808) |
0.0 | 0.8 | GO:0006305 | DNA alkylation(GO:0006305) DNA methylation(GO:0006306) |
0.0 | 0.1 | GO:0010766 | negative regulation of sodium ion transport(GO:0010766) |
0.0 | 0.1 | GO:0016137 | glycoside metabolic process(GO:0016137) glycoside catabolic process(GO:0016139) |
0.0 | 0.2 | GO:0016265 | obsolete death(GO:0016265) |
0.0 | 0.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.0 | GO:0034135 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) |
0.0 | 0.3 | GO:0003084 | positive regulation of systemic arterial blood pressure(GO:0003084) |
0.0 | 2.1 | GO:0006479 | protein methylation(GO:0006479) protein alkylation(GO:0008213) |
0.0 | 0.6 | GO:0045742 | positive regulation of epidermal growth factor receptor signaling pathway(GO:0045742) positive regulation of ERBB signaling pathway(GO:1901186) |
0.0 | 0.1 | GO:0045905 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
0.0 | 0.0 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.0 | 0.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
0.0 | 0.1 | GO:0031536 | positive regulation of exit from mitosis(GO:0031536) |
0.0 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 1.0 | GO:0032480 | negative regulation of type I interferon production(GO:0032480) |
0.0 | 0.5 | GO:0006044 | N-acetylglucosamine metabolic process(GO:0006044) |
0.0 | 5.2 | GO:0000377 | RNA splicing, via transesterification reactions with bulged adenosine as nucleophile(GO:0000377) mRNA splicing, via spliceosome(GO:0000398) |
0.0 | 0.1 | GO:0018343 | protein farnesylation(GO:0018343) |
0.0 | 0.4 | GO:0048873 | homeostasis of number of cells within a tissue(GO:0048873) |
0.0 | 0.2 | GO:0010591 | regulation of lamellipodium assembly(GO:0010591) |
0.0 | 0.1 | GO:0031929 | TOR signaling(GO:0031929) |
0.0 | 0.0 | GO:0019276 | UDP-N-acetylgalactosamine metabolic process(GO:0019276) |
0.0 | 0.3 | GO:0035335 | peptidyl-tyrosine dephosphorylation(GO:0035335) |
0.0 | 0.2 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
0.0 | 0.7 | GO:0000289 | nuclear-transcribed mRNA poly(A) tail shortening(GO:0000289) |
0.0 | 0.4 | GO:0051881 | regulation of mitochondrial membrane potential(GO:0051881) |
0.0 | 0.2 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.0 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.0 | 1.1 | GO:0006888 | ER to Golgi vesicle-mediated transport(GO:0006888) |
0.0 | 0.0 | GO:0034250 | positive regulation of cellular amide metabolic process(GO:0034250) |
0.0 | 0.1 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
0.0 | 0.7 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
0.0 | 0.2 | GO:0051770 | positive regulation of nitric-oxide synthase biosynthetic process(GO:0051770) |
0.0 | 0.8 | GO:1990266 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
0.0 | 0.5 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.0 | 2.7 | GO:0008643 | carbohydrate transport(GO:0008643) |
0.0 | 0.3 | GO:0015012 | heparan sulfate proteoglycan biosynthetic process(GO:0015012) |
0.0 | 0.6 | GO:0019933 | cAMP-mediated signaling(GO:0019933) |
0.0 | 0.5 | GO:1903321 | negative regulation of protein modification by small protein conjugation or removal(GO:1903321) |
0.0 | 0.2 | GO:0016574 | histone ubiquitination(GO:0016574) |
0.0 | 0.8 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
0.0 | 0.4 | GO:0030866 | cortical actin cytoskeleton organization(GO:0030866) |
0.0 | 0.1 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
0.0 | 0.3 | GO:0042354 | fucose catabolic process(GO:0019317) L-fucose metabolic process(GO:0042354) L-fucose catabolic process(GO:0042355) |
0.0 | 2.1 | GO:0000236 | mitotic prometaphase(GO:0000236) |
0.0 | 0.1 | GO:0001921 | positive regulation of receptor recycling(GO:0001921) |
0.0 | 0.3 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.0 | 0.0 | GO:0048569 | post-embryonic organ development(GO:0048569) |
0.0 | 1.7 | GO:0006521 | regulation of cellular amino acid metabolic process(GO:0006521) |
0.0 | 0.8 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
0.0 | 0.0 | GO:0048548 | regulation of pinocytosis(GO:0048548) |
0.0 | 0.1 | GO:0045074 | interleukin-10 biosynthetic process(GO:0042091) regulation of interleukin-10 biosynthetic process(GO:0045074) |
0.0 | 1.4 | GO:0006986 | response to unfolded protein(GO:0006986) |
0.0 | 0.2 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.0 | 0.1 | GO:0051310 | mitotic metaphase plate congression(GO:0007080) metaphase plate congression(GO:0051310) |
0.0 | 0.2 | GO:0045022 | early endosome to late endosome transport(GO:0045022) vesicle-mediated transport between endosomal compartments(GO:0098927) |
0.0 | 1.5 | GO:0006418 | tRNA aminoacylation for protein translation(GO:0006418) amino acid activation(GO:0043038) tRNA aminoacylation(GO:0043039) |
0.0 | 0.1 | GO:0043615 | astrocyte cell migration(GO:0043615) |
0.0 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
0.0 | 0.4 | GO:0042752 | regulation of circadian rhythm(GO:0042752) |
0.0 | 0.0 | GO:0031055 | chromatin remodeling at centromere(GO:0031055) |
0.0 | 0.8 | GO:0051028 | mRNA transport(GO:0051028) |
0.0 | 0.8 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
0.0 | 0.2 | GO:0048745 | smooth muscle tissue development(GO:0048745) |
0.0 | 0.0 | GO:0090205 | positive regulation of cholesterol metabolic process(GO:0090205) |
0.0 | 1.9 | GO:0000209 | protein polyubiquitination(GO:0000209) |
0.0 | 0.9 | GO:0061136 | regulation of proteasomal protein catabolic process(GO:0061136) |
0.0 | 0.2 | GO:0046504 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
0.0 | 0.5 | GO:0006094 | gluconeogenesis(GO:0006094) |
0.0 | 1.2 | GO:0006413 | translational initiation(GO:0006413) |
0.0 | 3.1 | GO:0006184 | obsolete GTP catabolic process(GO:0006184) |
0.0 | 0.1 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
0.0 | 0.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.0 | 0.2 | GO:0050872 | white fat cell differentiation(GO:0050872) |
0.0 | 0.5 | GO:0006071 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
0.0 | 0.1 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
0.0 | 0.1 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
0.0 | 0.0 | GO:0002328 | pro-B cell differentiation(GO:0002328) |
0.0 | 0.1 | GO:1903963 | arachidonic acid secretion(GO:0050482) arachidonate transport(GO:1903963) |
0.0 | 1.7 | GO:0006364 | rRNA processing(GO:0006364) |
0.0 | 0.1 | GO:0007256 | activation of JNKK activity(GO:0007256) |
0.0 | 0.0 | GO:0060081 | membrane hyperpolarization(GO:0060081) |
0.0 | 0.2 | GO:0046339 | diacylglycerol metabolic process(GO:0046339) |
0.0 | 0.0 | GO:0046629 | gamma-delta T cell differentiation(GO:0042492) gamma-delta T cell activation(GO:0046629) |
0.0 | 0.1 | GO:0021530 | spinal cord oligodendrocyte cell differentiation(GO:0021529) spinal cord oligodendrocyte cell fate specification(GO:0021530) oligodendrocyte cell fate specification(GO:0021778) oligodendrocyte cell fate commitment(GO:0021779) glial cell fate specification(GO:0021780) |
0.0 | 0.4 | GO:0006270 | DNA replication initiation(GO:0006270) |
0.0 | 0.2 | GO:0001776 | leukocyte homeostasis(GO:0001776) |
0.0 | 0.3 | GO:0036503 | ER-associated ubiquitin-dependent protein catabolic process(GO:0030433) ERAD pathway(GO:0036503) |
0.0 | 0.3 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
0.0 | 0.3 | GO:0005977 | glycogen metabolic process(GO:0005977) |
0.0 | 0.6 | GO:0070646 | protein modification by small protein removal(GO:0070646) |
0.0 | 0.1 | GO:0032733 | regulation of interleukin-10 production(GO:0032653) positive regulation of interleukin-10 production(GO:0032733) |
0.0 | 0.2 | GO:0032784 | regulation of DNA-templated transcription, elongation(GO:0032784) |
0.0 | 0.2 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.0 | 0.2 | GO:0006030 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) amino sugar catabolic process(GO:0046348) glucosamine-containing compound catabolic process(GO:1901072) |
0.0 | 0.3 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
0.0 | 0.2 | GO:0006101 | citrate metabolic process(GO:0006101) tricarboxylic acid metabolic process(GO:0072350) |
0.0 | 0.1 | GO:0006857 | oligopeptide transport(GO:0006857) |
0.0 | 0.1 | GO:0019441 | tryptophan catabolic process to kynurenine(GO:0019441) |
0.0 | 0.2 | GO:0071479 | cellular response to ionizing radiation(GO:0071479) |
0.0 | 0.7 | GO:0006338 | chromatin remodeling(GO:0006338) |
0.0 | 0.3 | GO:0045646 | regulation of erythrocyte differentiation(GO:0045646) |
0.0 | 5.5 | GO:0006412 | translation(GO:0006412) |
0.0 | 0.0 | GO:0051322 | anaphase(GO:0051322) |
0.0 | 0.1 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.0 | 0.2 | GO:0030317 | sperm motility(GO:0030317) |
0.0 | 0.2 | GO:0034199 | activation of protein kinase A activity(GO:0034199) |
0.0 | 0.1 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.0 | 0.9 | GO:0016126 | sterol biosynthetic process(GO:0016126) |
0.0 | 0.0 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
0.0 | 0.0 | GO:0042271 | susceptibility to natural killer cell mediated cytotoxicity(GO:0042271) |
0.0 | 0.2 | GO:0015074 | DNA integration(GO:0015074) |
0.0 | 0.1 | GO:0021527 | spinal cord association neuron differentiation(GO:0021527) |
0.0 | 0.3 | GO:0000080 | mitotic G1 phase(GO:0000080) |
0.0 | 0.3 | GO:0006662 | glycerol ether metabolic process(GO:0006662) ether metabolic process(GO:0018904) |
0.0 | 0.5 | GO:0006368 | transcription elongation from RNA polymerase II promoter(GO:0006368) |
0.0 | 0.0 | GO:0007412 | axon target recognition(GO:0007412) |
0.0 | 0.2 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
0.0 | 0.1 | GO:0033327 | Leydig cell differentiation(GO:0033327) |
0.0 | 0.0 | GO:0007100 | mitotic centrosome separation(GO:0007100) |
0.0 | 0.1 | GO:0036230 | granulocyte activation(GO:0036230) neutrophil activation(GO:0042119) |
0.0 | 0.3 | GO:0046676 | negative regulation of insulin secretion(GO:0046676) |
0.0 | 0.0 | GO:0051299 | centrosome separation(GO:0051299) |
0.0 | 0.0 | GO:0022038 | corpus callosum development(GO:0022038) |
0.0 | 0.2 | GO:0043666 | regulation of phosphoprotein phosphatase activity(GO:0043666) |
0.0 | 0.1 | GO:0051124 | synaptic growth at neuromuscular junction(GO:0051124) |
0.0 | 0.1 | GO:0042255 | ribosome assembly(GO:0042255) |
0.0 | 0.1 | GO:0060251 | regulation of glial cell proliferation(GO:0060251) |
0.0 | 0.2 | GO:2001020 | regulation of response to DNA damage stimulus(GO:2001020) |
0.0 | 0.2 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
0.0 | 0.2 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.0 | 0.2 | GO:1904030 | negative regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045736) negative regulation of cyclin-dependent protein kinase activity(GO:1904030) |
0.0 | 0.1 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
0.0 | 0.2 | GO:0045604 | regulation of epidermal cell differentiation(GO:0045604) |
0.0 | 0.0 | GO:0048570 | notochord morphogenesis(GO:0048570) |
0.0 | 0.1 | GO:0022614 | membrane to membrane docking(GO:0022614) |
0.0 | 0.4 | GO:0015914 | phospholipid transport(GO:0015914) |
0.0 | 0.1 | GO:0017121 | phospholipid scrambling(GO:0017121) |
0.0 | 0.3 | GO:0007157 | heterophilic cell-cell adhesion via plasma membrane cell adhesion molecules(GO:0007157) |
0.0 | 0.1 | GO:0030002 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
0.0 | 0.1 | GO:0042726 | flavin-containing compound metabolic process(GO:0042726) |
0.0 | 0.1 | GO:0006570 | tyrosine metabolic process(GO:0006570) |
0.0 | 0.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.0 | 0.0 | GO:0042772 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) DNA damage response, signal transduction resulting in transcription(GO:0042772) |
0.0 | 0.0 | GO:0006154 | adenosine catabolic process(GO:0006154) |
0.0 | 0.2 | GO:0051320 | mitotic S phase(GO:0000084) S phase(GO:0051320) |
0.0 | 0.1 | GO:0006402 | mRNA catabolic process(GO:0006402) |
0.0 | 0.3 | GO:0008633 | obsolete activation of pro-apoptotic gene products(GO:0008633) |
0.0 | 0.4 | GO:0006302 | double-strand break repair(GO:0006302) |
0.0 | 0.0 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0019079 | viral genome replication(GO:0019079) |
0.0 | 0.0 | GO:0035414 | negative regulation of catenin import into nucleus(GO:0035414) |
0.0 | 0.1 | GO:0006103 | 2-oxoglutarate metabolic process(GO:0006103) |
0.0 | 0.0 | GO:0034139 | regulation of toll-like receptor 3 signaling pathway(GO:0034139) positive regulation of toll-like receptor 4 signaling pathway(GO:0034145) |
0.0 | 0.3 | GO:0007602 | phototransduction(GO:0007602) |
0.0 | 0.5 | GO:0045454 | cell redox homeostasis(GO:0045454) |
0.0 | 0.4 | GO:0003333 | amino acid transmembrane transport(GO:0003333) |
0.0 | 0.1 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.5 | GO:0031647 | regulation of protein stability(GO:0031647) |
0.0 | 0.1 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
0.0 | 0.0 | GO:0010891 | negative regulation of sequestering of triglyceride(GO:0010891) |
0.0 | 0.0 | GO:0051387 | negative regulation of neurotrophin TRK receptor signaling pathway(GO:0051387) |
0.0 | 0.1 | GO:0006388 | RNA splicing, via endonucleolytic cleavage and ligation(GO:0000394) tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.0 | 2.7 | GO:0006396 | RNA processing(GO:0006396) |
0.0 | 0.1 | GO:0001916 | regulation of T cell mediated cytotoxicity(GO:0001914) positive regulation of T cell mediated cytotoxicity(GO:0001916) |
0.0 | 0.2 | GO:0007340 | acrosome reaction(GO:0007340) |
0.0 | 0.0 | GO:0002478 | antigen processing and presentation of exogenous peptide antigen(GO:0002478) |
0.0 | 0.0 | GO:0035581 | sequestering of extracellular ligand from receptor(GO:0035581) sequestering of TGFbeta in extracellular matrix(GO:0035583) protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) extracellular regulation of signal transduction(GO:1900115) extracellular negative regulation of signal transduction(GO:1900116) |
0.0 | 0.1 | GO:0072599 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.0 | 0.0 | GO:0021873 | forebrain neuroblast division(GO:0021873) |
0.0 | 0.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.0 | 0.0 | GO:0007506 | gonadal mesoderm development(GO:0007506) |
0.0 | 0.0 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.0 | 0.1 | GO:0035020 | regulation of Rac protein signal transduction(GO:0035020) |
0.0 | 0.0 | GO:0033194 | response to hydroperoxide(GO:0033194) |
0.0 | 0.0 | GO:0051024 | positive regulation of immunoglobulin secretion(GO:0051024) |
0.0 | 0.3 | GO:0046209 | nitric oxide metabolic process(GO:0046209) reactive nitrogen species metabolic process(GO:2001057) |
0.0 | 0.1 | GO:0044273 | sulfur compound catabolic process(GO:0044273) |
0.0 | 0.3 | GO:0071804 | cellular potassium ion transport(GO:0071804) potassium ion transmembrane transport(GO:0071805) |
0.0 | 0.1 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
0.0 | 0.1 | GO:0006787 | porphyrin-containing compound catabolic process(GO:0006787) tetrapyrrole catabolic process(GO:0033015) heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
0.0 | 0.1 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.0 | 0.2 | GO:0006904 | vesicle docking involved in exocytosis(GO:0006904) |
0.0 | 0.1 | GO:0007030 | Golgi organization(GO:0007030) |
0.0 | 0.1 | GO:0007216 | G-protein coupled glutamate receptor signaling pathway(GO:0007216) |
0.0 | 0.1 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
0.0 | 0.0 | GO:0006085 | acetyl-CoA biosynthetic process(GO:0006085) |
0.0 | 0.0 | GO:0030432 | peristalsis(GO:0030432) |
0.0 | 0.0 | GO:0070059 | intrinsic apoptotic signaling pathway in response to endoplasmic reticulum stress(GO:0070059) |
0.0 | 0.1 | GO:1901216 | positive regulation of neuron apoptotic process(GO:0043525) positive regulation of neuron death(GO:1901216) |
0.0 | 0.3 | GO:0006672 | ceramide metabolic process(GO:0006672) |
0.0 | 0.0 | GO:0019883 | antigen processing and presentation of endogenous antigen(GO:0019883) |
0.0 | 0.1 | GO:0002456 | T cell mediated immunity(GO:0002456) |
0.0 | 0.1 | GO:0010212 | response to ionizing radiation(GO:0010212) |
0.0 | 0.0 | GO:0021781 | glial cell fate commitment(GO:0021781) |
0.0 | 0.0 | GO:0072141 | mesangial cell differentiation(GO:0072007) kidney interstitial fibroblast differentiation(GO:0072071) renal interstitial fibroblast development(GO:0072141) mesangial cell development(GO:0072143) pericyte cell differentiation(GO:1904238) |
0.0 | 0.0 | GO:0042159 | lipoprotein catabolic process(GO:0042159) |
0.0 | 0.0 | GO:0034763 | negative regulation of transmembrane transport(GO:0034763) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.7 | 2.1 | GO:0072487 | MSL complex(GO:0072487) |
0.6 | 1.8 | GO:0032593 | insulin-responsive compartment(GO:0032593) |
0.5 | 2.7 | GO:0042599 | lamellar body(GO:0042599) |
0.5 | 1.9 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
0.4 | 1.1 | GO:0043625 | delta DNA polymerase complex(GO:0043625) |
0.4 | 1.4 | GO:0031262 | Ndc80 complex(GO:0031262) |
0.3 | 0.9 | GO:0016939 | kinesin II complex(GO:0016939) |
0.3 | 1.2 | GO:0032059 | bleb(GO:0032059) |
0.3 | 0.9 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
0.3 | 1.7 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
0.3 | 1.1 | GO:0005964 | phosphorylase kinase complex(GO:0005964) |
0.2 | 0.5 | GO:0070062 | extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
0.2 | 0.9 | GO:0005826 | actomyosin contractile ring(GO:0005826) |
0.2 | 1.3 | GO:0042575 | DNA polymerase complex(GO:0042575) |
0.2 | 2.6 | GO:0045263 | proton-transporting ATP synthase complex, coupling factor F(o)(GO:0045263) |
0.2 | 1.3 | GO:0042382 | paraspeckles(GO:0042382) |
0.2 | 0.8 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
0.2 | 1.5 | GO:0070688 | MLL5-L complex(GO:0070688) |
0.2 | 0.6 | GO:0060200 | clathrin-sculpted acetylcholine transport vesicle(GO:0060200) clathrin-sculpted acetylcholine transport vesicle membrane(GO:0060201) |
0.2 | 1.2 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.2 | 0.6 | GO:0045254 | pyruvate dehydrogenase complex(GO:0045254) |
0.2 | 0.6 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
0.2 | 0.5 | GO:0032809 | neuronal cell body membrane(GO:0032809) cell body membrane(GO:0044298) |
0.2 | 1.1 | GO:0001527 | microfibril(GO:0001527) |
0.2 | 1.4 | GO:0019773 | proteasome core complex, alpha-subunit complex(GO:0019773) |
0.2 | 0.5 | GO:0071818 | BAT3 complex(GO:0071818) ER membrane insertion complex(GO:0072379) |
0.2 | 1.4 | GO:0042555 | MCM complex(GO:0042555) |
0.2 | 1.0 | GO:0005869 | dynactin complex(GO:0005869) |
0.2 | 0.5 | GO:0030008 | TRAPP complex(GO:0030008) |
0.2 | 0.8 | GO:0031305 | integral component of mitochondrial inner membrane(GO:0031305) |
0.2 | 0.9 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
0.1 | 1.8 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
0.1 | 1.1 | GO:0016342 | catenin complex(GO:0016342) |
0.1 | 1.5 | GO:0032039 | integrator complex(GO:0032039) |
0.1 | 0.5 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
0.1 | 0.7 | GO:0000805 | X chromosome(GO:0000805) |
0.1 | 0.5 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
0.1 | 2.0 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
0.1 | 0.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
0.1 | 0.5 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
0.1 | 0.7 | GO:0005883 | neurofilament(GO:0005883) |
0.1 | 1.3 | GO:0008278 | cohesin complex(GO:0008278) |
0.1 | 1.1 | GO:0008250 | oligosaccharyltransferase complex(GO:0008250) |
0.1 | 1.7 | GO:0046930 | pore complex(GO:0046930) |
0.1 | 0.7 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.1 | 1.5 | GO:0016581 | NuRD complex(GO:0016581) CHD-type complex(GO:0090545) nuclear transcriptional repressor complex(GO:0090568) |
0.1 | 0.7 | GO:0016461 | unconventional myosin complex(GO:0016461) |
0.1 | 0.6 | GO:0005682 | U5 snRNP(GO:0005682) |
0.1 | 4.0 | GO:0030964 | mitochondrial respiratory chain complex I(GO:0005747) NADH dehydrogenase complex(GO:0030964) respiratory chain complex I(GO:0045271) |
0.1 | 0.4 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
0.1 | 0.6 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
0.1 | 3.8 | GO:0005814 | centriole(GO:0005814) |
0.1 | 0.5 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
0.1 | 5.6 | GO:0000786 | nucleosome(GO:0000786) |
0.1 | 0.6 | GO:0030122 | AP-2 adaptor complex(GO:0030122) clathrin coat of endocytic vesicle(GO:0030128) |
0.1 | 0.5 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.1 | 0.9 | GO:0017119 | Golgi transport complex(GO:0017119) |
0.1 | 0.8 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.1 | 0.2 | GO:0032444 | activin responsive factor complex(GO:0032444) |
0.1 | 0.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
0.1 | 1.0 | GO:0030867 | rough endoplasmic reticulum membrane(GO:0030867) |
0.1 | 0.3 | GO:0031371 | ubiquitin conjugating enzyme complex(GO:0031371) |
0.1 | 0.6 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
0.1 | 0.7 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.1 | 0.5 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.1 | 3.7 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
0.1 | 0.5 | GO:0048500 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.1 | 1.1 | GO:0005801 | cis-Golgi network(GO:0005801) |
0.1 | 0.4 | GO:0030894 | replisome(GO:0030894) nuclear replisome(GO:0043601) |
0.1 | 0.3 | GO:0045120 | pronucleus(GO:0045120) |
0.1 | 0.9 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
0.1 | 0.3 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
0.1 | 0.9 | GO:0043189 | H4/H2A histone acetyltransferase complex(GO:0043189) H4 histone acetyltransferase complex(GO:1902562) |
0.1 | 0.2 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
0.1 | 0.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
0.1 | 0.4 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
0.1 | 0.3 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
0.1 | 0.2 | GO:0005686 | U2 snRNP(GO:0005686) |
0.1 | 6.8 | GO:0005681 | spliceosomal complex(GO:0005681) |
0.1 | 0.2 | GO:0070695 | FHF complex(GO:0070695) |
0.1 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
0.1 | 1.0 | GO:0031519 | PcG protein complex(GO:0031519) |
0.1 | 0.4 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.1 | 0.2 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
0.1 | 0.7 | GO:0016235 | aggresome(GO:0016235) |
0.1 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.1 | 0.4 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.1 | 0.7 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.1 | 0.1 | GO:0031932 | TORC2 complex(GO:0031932) |
0.1 | 0.2 | GO:0005775 | vacuolar lumen(GO:0005775) |
0.1 | 0.1 | GO:0005664 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.1 | 0.3 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
0.0 | 0.2 | GO:0031211 | palmitoyltransferase complex(GO:0002178) serine C-palmitoyltransferase complex(GO:0017059) endoplasmic reticulum palmitoyltransferase complex(GO:0031211) |
0.0 | 3.7 | GO:0016607 | nuclear speck(GO:0016607) |
0.0 | 0.2 | GO:0030904 | retromer complex(GO:0030904) |
0.0 | 0.3 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.0 | 0.2 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.0 | 2.0 | GO:0055037 | recycling endosome(GO:0055037) |
0.0 | 3.9 | GO:0042579 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.0 | 2.4 | GO:0019897 | extrinsic component of plasma membrane(GO:0019897) |
0.0 | 0.1 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
0.0 | 1.6 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.2 | GO:0042598 | obsolete vesicular fraction(GO:0042598) |
0.0 | 0.3 | GO:0071203 | WASH complex(GO:0071203) |
0.0 | 0.5 | GO:0016514 | SWI/SNF complex(GO:0016514) |
0.0 | 2.6 | GO:0031227 | intrinsic component of endoplasmic reticulum membrane(GO:0031227) |
0.0 | 0.1 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
0.0 | 0.1 | GO:0005797 | Golgi medial cisterna(GO:0005797) |
0.0 | 1.6 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
0.0 | 0.2 | GO:0030914 | STAGA complex(GO:0030914) |
0.0 | 1.7 | GO:0000502 | proteasome complex(GO:0000502) |
0.0 | 0.8 | GO:0001725 | stress fiber(GO:0001725) contractile actin filament bundle(GO:0097517) |
0.0 | 1.1 | GO:0015935 | small ribosomal subunit(GO:0015935) |
0.0 | 0.5 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.0 | 0.1 | GO:0030686 | 90S preribosome(GO:0030686) PeBoW complex(GO:0070545) |
0.0 | 0.1 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
0.0 | 0.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
0.0 | 0.2 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 0.1 | GO:0071437 | invadopodium(GO:0071437) |
0.0 | 0.1 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
0.0 | 0.4 | GO:0033276 | transcription factor TFTC complex(GO:0033276) |
0.0 | 0.3 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
0.0 | 0.3 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
0.0 | 0.1 | GO:0000137 | Golgi cis cisterna(GO:0000137) |
0.0 | 0.2 | GO:0034366 | spherical high-density lipoprotein particle(GO:0034366) |
0.0 | 0.1 | GO:0000791 | euchromatin(GO:0000791) |
0.0 | 2.2 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.0 | 1.8 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
0.0 | 0.4 | GO:0031201 | SNARE complex(GO:0031201) |
0.0 | 1.2 | GO:0031301 | integral component of organelle membrane(GO:0031301) |
0.0 | 0.3 | GO:0000421 | autophagosome membrane(GO:0000421) |
0.0 | 1.2 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
0.0 | 0.4 | GO:0045335 | phagocytic vesicle(GO:0045335) |
0.0 | 0.1 | GO:0070461 | SAGA-type complex(GO:0070461) |
0.0 | 0.2 | GO:0000780 | condensed nuclear chromosome, centromeric region(GO:0000780) |
0.0 | 0.4 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 2.5 | GO:0031965 | nuclear membrane(GO:0031965) |
0.0 | 0.0 | GO:0005827 | polar microtubule(GO:0005827) |
0.0 | 0.1 | GO:0048188 | Set1C/COMPASS complex(GO:0048188) |
0.0 | 0.8 | GO:0030496 | midbody(GO:0030496) |
0.0 | 0.1 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.0 | 0.8 | GO:0005802 | trans-Golgi network(GO:0005802) |
0.0 | 0.3 | GO:0032993 | protein-DNA complex(GO:0032993) |
0.0 | 0.2 | GO:0000784 | nuclear chromosome, telomeric region(GO:0000784) |
0.0 | 0.1 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
0.0 | 0.2 | GO:0030315 | T-tubule(GO:0030315) |
0.0 | 0.5 | GO:0031514 | motile cilium(GO:0031514) |
0.0 | 0.1 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
0.0 | 0.2 | GO:0001518 | voltage-gated sodium channel complex(GO:0001518) |
0.0 | 0.1 | GO:0005896 | interleukin-6 receptor complex(GO:0005896) |
0.0 | 0.1 | GO:0031105 | septin complex(GO:0031105) septin cytoskeleton(GO:0032156) |
0.0 | 0.6 | GO:0005793 | endoplasmic reticulum-Golgi intermediate compartment(GO:0005793) |
0.0 | 1.3 | GO:0000785 | chromatin(GO:0000785) |
0.0 | 0.5 | GO:0043204 | perikaryon(GO:0043204) |
0.0 | 0.3 | GO:0000118 | histone deacetylase complex(GO:0000118) |
0.0 | 0.1 | GO:0042589 | zymogen granule membrane(GO:0042589) |
0.0 | 0.5 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.1 | GO:0001673 | male germ cell nucleus(GO:0001673) |
0.0 | 0.1 | GO:0097425 | smooth endoplasmic reticulum membrane(GO:0030868) smooth endoplasmic reticulum part(GO:0097425) |
0.0 | 3.4 | GO:0031966 | mitochondrial membrane(GO:0031966) |
0.0 | 0.1 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.0 | 0.1 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.0 | 0.7 | GO:0048770 | melanosome(GO:0042470) pigment granule(GO:0048770) |
0.0 | 0.1 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.0 | 0.9 | GO:0016604 | nuclear body(GO:0016604) |
0.0 | 8.7 | GO:0005739 | mitochondrion(GO:0005739) |
0.0 | 1.4 | GO:0000151 | ubiquitin ligase complex(GO:0000151) |
0.0 | 0.0 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
0.0 | 0.3 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
0.0 | 5.4 | GO:0005654 | nucleoplasm(GO:0005654) |
0.0 | 0.0 | GO:0070852 | cell body fiber(GO:0070852) |
0.0 | 0.1 | GO:0030684 | preribosome(GO:0030684) |
0.0 | 0.4 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
0.0 | 0.1 | GO:0033179 | proton-transporting V-type ATPase, V0 domain(GO:0033179) |
0.0 | 0.0 | GO:0097525 | spliceosomal snRNP complex(GO:0097525) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.5 | 1.6 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.4 | 1.1 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.3 | 1.0 | GO:0003896 | DNA primase activity(GO:0003896) |
0.3 | 1.0 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
0.3 | 0.9 | GO:1990939 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
0.3 | 0.9 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.3 | 0.8 | GO:0008475 | procollagen-lysine 5-dioxygenase activity(GO:0008475) |
0.3 | 2.2 | GO:0001671 | ATPase activator activity(GO:0001671) |
0.3 | 1.1 | GO:0004689 | phosphorylase kinase activity(GO:0004689) |
0.3 | 0.5 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.3 | 1.0 | GO:0070061 | fructose binding(GO:0070061) |
0.3 | 0.8 | GO:0098599 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
0.2 | 0.7 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.2 | 1.4 | GO:0050733 | RS domain binding(GO:0050733) |
0.2 | 2.6 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.7 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
0.2 | 0.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.2 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.2 | 0.6 | GO:0047499 | calcium-independent phospholipase A2 activity(GO:0047499) |
0.2 | 0.6 | GO:0015165 | pyrimidine nucleotide-sugar transmembrane transporter activity(GO:0015165) |
0.2 | 1.1 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.2 | 0.6 | GO:0050544 | arachidonic acid binding(GO:0050544) |
0.2 | 1.0 | GO:0017108 | 5'-flap endonuclease activity(GO:0017108) |
0.2 | 2.1 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.6 | GO:0004739 | pyruvate dehydrogenase activity(GO:0004738) pyruvate dehydrogenase (acetyl-transferring) activity(GO:0004739) |
0.2 | 1.5 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.2 | 0.6 | GO:0070644 | vitamin D response element binding(GO:0070644) |
0.2 | 2.0 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.2 | 0.5 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
0.2 | 1.1 | GO:0008159 | obsolete positive transcription elongation factor activity(GO:0008159) |
0.2 | 0.9 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.2 | GO:0016896 | exoribonuclease activity, producing 5'-phosphomonoesters(GO:0016896) |
0.2 | 0.8 | GO:0004459 | L-lactate dehydrogenase activity(GO:0004459) |
0.2 | 0.5 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
0.2 | 0.7 | GO:0015349 | thyroid hormone transmembrane transporter activity(GO:0015349) |
0.2 | 0.8 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.2 | 0.8 | GO:0052813 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
0.2 | 0.9 | GO:0015288 | porin activity(GO:0015288) |
0.2 | 1.5 | GO:0005123 | death receptor binding(GO:0005123) |
0.1 | 0.1 | GO:1901474 | azole transporter activity(GO:0045118) azole transmembrane transporter activity(GO:1901474) |
0.1 | 0.7 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
0.1 | 0.6 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
0.1 | 0.8 | GO:0004969 | histamine receptor activity(GO:0004969) |
0.1 | 0.7 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
0.1 | 0.7 | GO:0016717 | oxidoreductase activity, acting on paired donors, with oxidation of a pair of donors resulting in the reduction of molecular oxygen to two molecules of water(GO:0016717) |
0.1 | 1.3 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
0.1 | 0.5 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
0.1 | 0.5 | GO:0004427 | inorganic diphosphatase activity(GO:0004427) |
0.1 | 0.6 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.1 | 0.4 | GO:0015562 | efflux transmembrane transporter activity(GO:0015562) |
0.1 | 0.5 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 0.5 | GO:0016531 | copper chaperone activity(GO:0016531) |
0.1 | 1.1 | GO:0004579 | dolichyl-diphosphooligosaccharide-protein glycotransferase activity(GO:0004579) |
0.1 | 1.0 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
0.1 | 0.7 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
0.1 | 0.6 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
0.1 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
0.1 | 0.5 | GO:0004383 | guanylate cyclase activity(GO:0004383) |
0.1 | 0.5 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
0.1 | 2.9 | GO:0051119 | sugar transmembrane transporter activity(GO:0051119) |
0.1 | 0.1 | GO:0035514 | DNA demethylase activity(GO:0035514) DNA-N1-methyladenine dioxygenase activity(GO:0043734) |
0.1 | 0.6 | GO:0015556 | C4-dicarboxylate transmembrane transporter activity(GO:0015556) |
0.1 | 0.6 | GO:0015520 | tetracycline:proton antiporter activity(GO:0015520) |
0.1 | 0.6 | GO:0004904 | interferon receptor activity(GO:0004904) |
0.1 | 0.1 | GO:0048256 | flap endonuclease activity(GO:0048256) |
0.1 | 0.7 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.1 | 0.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
0.1 | 0.3 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
0.1 | 0.3 | GO:0004505 | phenylalanine 4-monooxygenase activity(GO:0004505) |
0.1 | 0.6 | GO:0031996 | thioesterase binding(GO:0031996) |
0.1 | 0.4 | GO:0004616 | phosphogluconate dehydrogenase (decarboxylating) activity(GO:0004616) |
0.1 | 0.7 | GO:0030371 | translation repressor activity(GO:0030371) |
0.1 | 1.2 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
0.1 | 1.9 | GO:0070003 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
0.1 | 0.4 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
0.1 | 1.3 | GO:0046933 | proton-transporting ATP synthase activity, rotational mechanism(GO:0046933) |
0.1 | 0.3 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
0.1 | 0.3 | GO:0051864 | histone demethylase activity (H3-K36 specific)(GO:0051864) |
0.1 | 1.1 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
0.1 | 0.2 | GO:0008327 | methyl-CpG binding(GO:0008327) |
0.1 | 0.4 | GO:0004185 | serine-type carboxypeptidase activity(GO:0004185) |
0.1 | 0.6 | GO:0051920 | peroxiredoxin activity(GO:0051920) |
0.1 | 0.3 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.1 | 0.6 | GO:0070628 | proteasome binding(GO:0070628) |
0.1 | 0.6 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
0.1 | 0.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
0.1 | 0.2 | GO:0032552 | deoxyribonucleotide binding(GO:0032552) |
0.1 | 0.5 | GO:0042043 | neurexin family protein binding(GO:0042043) |
0.1 | 0.3 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.1 | 0.2 | GO:0017060 | 3-galactosyl-N-acetylglucosaminide 4-alpha-L-fucosyltransferase activity(GO:0017060) |
0.1 | 0.1 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
0.1 | 0.5 | GO:0030507 | spectrin binding(GO:0030507) |
0.1 | 0.1 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
0.1 | 0.5 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
0.1 | 3.1 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.1 | 0.3 | GO:0004749 | ribose phosphate diphosphokinase activity(GO:0004749) |
0.1 | 0.4 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
0.1 | 0.3 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
0.1 | 1.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
0.1 | 0.3 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.1 | 0.2 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.1 | 0.2 | GO:0004758 | serine C-palmitoyltransferase activity(GO:0004758) C-palmitoyltransferase activity(GO:0016454) |
0.1 | 0.3 | GO:0005536 | glucose binding(GO:0005536) |
0.1 | 0.7 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
0.1 | 0.5 | GO:0008889 | glycerophosphodiester phosphodiesterase activity(GO:0008889) |
0.1 | 0.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.1 | 0.6 | GO:0016866 | intramolecular transferase activity(GO:0016866) |
0.1 | 0.2 | GO:0004775 | succinate-CoA ligase (ADP-forming) activity(GO:0004775) |
0.1 | 1.2 | GO:0035064 | methylated histone binding(GO:0035064) |
0.1 | 0.2 | GO:0016416 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
0.1 | 0.9 | GO:1905030 | voltage-gated sodium channel activity(GO:0005248) voltage-gated ion channel activity involved in regulation of postsynaptic membrane potential(GO:1905030) |
0.1 | 0.2 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
0.1 | 0.2 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
0.1 | 0.3 | GO:0008409 | 5'-3' exonuclease activity(GO:0008409) |
0.1 | 0.2 | GO:0031127 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
0.1 | 1.8 | GO:0008137 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
0.1 | 0.2 | GO:0004516 | nicotinate phosphoribosyltransferase activity(GO:0004516) |
0.1 | 0.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.1 | 1.4 | GO:0003724 | RNA helicase activity(GO:0003724) |
0.1 | 2.9 | GO:0008276 | protein methyltransferase activity(GO:0008276) |
0.1 | 0.4 | GO:0005522 | profilin binding(GO:0005522) |
0.1 | 1.8 | GO:0003704 | obsolete specific RNA polymerase II transcription factor activity(GO:0003704) |
0.1 | 0.2 | GO:0034186 | apolipoprotein A-I binding(GO:0034186) |
0.1 | 1.3 | GO:0000049 | tRNA binding(GO:0000049) |
0.1 | 0.5 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
0.1 | 0.3 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
0.1 | 4.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.2 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.9 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.1 | 0.9 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.1 | 0.5 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.1 | 0.2 | GO:0004828 | serine-tRNA ligase activity(GO:0004828) |
0.0 | 0.5 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
0.0 | 1.3 | GO:0016831 | carboxy-lyase activity(GO:0016831) |
0.0 | 2.4 | GO:0003743 | translation initiation factor activity(GO:0003743) |
0.0 | 0.2 | GO:0003886 | DNA (cytosine-5-)-methyltransferase activity(GO:0003886) |
0.0 | 4.3 | GO:0016566 | obsolete specific transcriptional repressor activity(GO:0016566) |
0.0 | 0.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
0.0 | 0.8 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.0 | 0.3 | GO:0001085 | RNA polymerase II transcription factor binding(GO:0001085) |
0.0 | 0.7 | GO:0004115 | 3',5'-cyclic-AMP phosphodiesterase activity(GO:0004115) |
0.0 | 0.5 | GO:0004467 | long-chain fatty acid-CoA ligase activity(GO:0004467) |
0.0 | 0.6 | GO:0000155 | phosphorelay sensor kinase activity(GO:0000155) |
0.0 | 1.1 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.0 | 0.6 | GO:0004659 | prenyltransferase activity(GO:0004659) |
0.0 | 0.9 | GO:0015485 | cholesterol binding(GO:0015485) |
0.0 | 1.0 | GO:0003684 | damaged DNA binding(GO:0003684) |
0.0 | 0.6 | GO:0019894 | kinesin binding(GO:0019894) |
0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.0 | 0.0 | GO:0035197 | siRNA binding(GO:0035197) |
0.0 | 0.1 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
0.0 | 0.9 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.0 | 0.2 | GO:0009922 | fatty acid elongase activity(GO:0009922) |
0.0 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
0.0 | 0.6 | GO:0004198 | calcium-dependent cysteine-type endopeptidase activity(GO:0004198) |
0.0 | 0.3 | GO:0016986 | obsolete transcription initiation factor activity(GO:0016986) |
0.0 | 0.4 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.0 | 0.6 | GO:0004835 | tubulin-tyrosine ligase activity(GO:0004835) |
0.0 | 0.2 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
0.0 | 0.5 | GO:0016830 | carbon-carbon lyase activity(GO:0016830) |
0.0 | 0.3 | GO:0090079 | translation regulator activity, nucleic acid binding(GO:0090079) |
0.0 | 0.1 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
0.0 | 0.1 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.0 | 0.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.0 | 0.1 | GO:0019166 | trans-2-enoyl-CoA reductase (NADPH) activity(GO:0019166) |
0.0 | 0.8 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
0.0 | 0.2 | GO:0080025 | phosphatidylinositol-3,5-bisphosphate binding(GO:0080025) |
0.0 | 0.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.0 | 0.2 | GO:0004559 | alpha-mannosidase activity(GO:0004559) |
0.0 | 2.3 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.0 | 0.1 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.0 | 1.0 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.0 | 2.3 | GO:0031625 | ubiquitin protein ligase binding(GO:0031625) ubiquitin-like protein ligase binding(GO:0044389) |
0.0 | 2.1 | GO:0008565 | protein transporter activity(GO:0008565) |
0.0 | 0.2 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.0 | 0.0 | GO:0004532 | exoribonuclease activity(GO:0004532) |
0.0 | 0.4 | GO:0004697 | protein kinase C activity(GO:0004697) |
0.0 | 0.5 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
0.0 | 0.2 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.0 | 0.2 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.0 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.5 | GO:0004527 | exonuclease activity(GO:0004527) |
0.0 | 0.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.0 | 1.9 | GO:0051082 | unfolded protein binding(GO:0051082) |
0.0 | 0.1 | GO:0016362 | activin receptor activity, type II(GO:0016362) |
0.0 | 0.2 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.0 | 0.2 | GO:0046790 | virion binding(GO:0046790) |
0.0 | 0.1 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
0.0 | 0.2 | GO:0019992 | diacylglycerol binding(GO:0019992) |
0.0 | 2.2 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.9 | GO:0001104 | transcription factor activity, RNA polymerase II transcription factor binding(GO:0001076) RNA polymerase II transcription cofactor activity(GO:0001104) |
0.0 | 0.4 | GO:0017017 | MAP kinase tyrosine/serine/threonine phosphatase activity(GO:0017017) |
0.0 | 0.3 | GO:0034593 | phosphatidylinositol bisphosphate phosphatase activity(GO:0034593) |
0.0 | 0.5 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
0.0 | 0.1 | GO:0070412 | R-SMAD binding(GO:0070412) |
0.0 | 0.3 | GO:0046875 | ephrin receptor binding(GO:0046875) |
0.0 | 6.2 | GO:0016874 | ligase activity(GO:0016874) |
0.0 | 0.5 | GO:0035250 | UDP-galactosyltransferase activity(GO:0035250) |
0.0 | 0.1 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
0.0 | 0.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.0 | 0.1 | GO:0030306 | ADP-ribosylation factor binding(GO:0030306) |
0.0 | 0.0 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.0 | 1.0 | GO:0004180 | carboxypeptidase activity(GO:0004180) |
0.0 | 0.1 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.0 | 0.3 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
0.0 | 2.3 | GO:0042626 | ATPase activity, coupled to transmembrane movement of substances(GO:0042626) |
0.0 | 0.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.0 | 0.9 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
0.0 | 1.0 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.0 | 1.0 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.0 | 0.2 | GO:0045182 | translation regulator activity(GO:0045182) |
0.0 | 0.1 | GO:0017169 | CDP-alcohol phosphatidyltransferase activity(GO:0017169) |
0.0 | 0.3 | GO:0005527 | macrolide binding(GO:0005527) FK506 binding(GO:0005528) |
0.0 | 0.1 | GO:0016655 | oxidoreductase activity, acting on NAD(P)H, quinone or similar compound as acceptor(GO:0016655) |
0.0 | 0.2 | GO:0004568 | chitinase activity(GO:0004568) |
0.0 | 0.7 | GO:0003678 | DNA helicase activity(GO:0003678) |
0.0 | 0.9 | GO:0019783 | ubiquitin-like protein-specific protease activity(GO:0019783) |
0.0 | 0.1 | GO:0016290 | palmitoyl-CoA hydrolase activity(GO:0016290) |
0.0 | 0.3 | GO:0001968 | fibronectin binding(GO:0001968) |
0.0 | 0.2 | GO:0008417 | fucosyltransferase activity(GO:0008417) |
0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
0.0 | 12.1 | GO:0003723 | RNA binding(GO:0003723) |
0.0 | 0.5 | GO:0019003 | GDP binding(GO:0019003) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.3 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.0 | 0.1 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
0.0 | 0.1 | GO:0031369 | translation initiation factor binding(GO:0031369) |
0.0 | 0.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.0 | 0.2 | GO:0004908 | interleukin-1 receptor activity(GO:0004908) |
0.0 | 0.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.0 | 0.1 | GO:0045502 | dynein binding(GO:0045502) |
0.0 | 0.9 | GO:0019888 | protein phosphatase regulator activity(GO:0019888) |
0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) type 1 angiotensin receptor binding(GO:0031702) |
0.0 | 0.1 | GO:0033613 | activating transcription factor binding(GO:0033613) |
0.0 | 0.5 | GO:0042169 | SH2 domain binding(GO:0042169) |
0.0 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
0.0 | 0.1 | GO:0000832 | inositol hexakisphosphate kinase activity(GO:0000828) inositol hexakisphosphate 5-kinase activity(GO:0000832) |
0.0 | 0.1 | GO:0031593 | polyubiquitin binding(GO:0031593) |
0.0 | 0.0 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.0 | 0.1 | GO:0043295 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.0 | 0.5 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.0 | 0.8 | GO:0003707 | steroid hormone receptor activity(GO:0003707) |
0.0 | 0.8 | GO:0004386 | helicase activity(GO:0004386) |
0.0 | 0.1 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
0.0 | 0.7 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.0 | 0.1 | GO:0070492 | oligosaccharide binding(GO:0070492) |
0.0 | 0.5 | GO:0015036 | disulfide oxidoreductase activity(GO:0015036) |
0.0 | 0.9 | GO:0008017 | microtubule binding(GO:0008017) |
0.0 | 5.2 | GO:0005525 | GTP binding(GO:0005525) |
0.0 | 0.2 | GO:0051117 | ATPase binding(GO:0051117) |
0.0 | 0.1 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.0 | 0.4 | GO:0017046 | peptide hormone binding(GO:0017046) |
0.0 | 0.1 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.0 | 0.1 | GO:0099602 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.0 | 0.0 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
0.0 | 0.4 | GO:0008375 | acetylglucosaminyltransferase activity(GO:0008375) |
0.0 | 0.3 | GO:0030170 | pyridoxal phosphate binding(GO:0030170) |
0.0 | 0.6 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.0 | 0.2 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.0 | 0.1 | GO:0004047 | aminomethyltransferase activity(GO:0004047) |
0.0 | 0.1 | GO:0008172 | S-methyltransferase activity(GO:0008172) |
0.0 | 0.9 | GO:0004518 | nuclease activity(GO:0004518) |
0.0 | 0.2 | GO:0050681 | androgen receptor binding(GO:0050681) |
0.0 | 0.1 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.0 | 0.0 | GO:0030375 | thyroid hormone receptor coactivator activity(GO:0030375) |
0.0 | 0.1 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.0 | 0.0 | GO:0047045 | testosterone 17-beta-dehydrogenase (NADP+) activity(GO:0047045) |
0.0 | 0.2 | GO:0008483 | transaminase activity(GO:0008483) |
0.0 | 0.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.0 | 0.1 | GO:0070016 | armadillo repeat domain binding(GO:0070016) |
0.0 | 0.3 | GO:0015179 | L-amino acid transmembrane transporter activity(GO:0015179) |
0.0 | 0.1 | GO:0031490 | chromatin DNA binding(GO:0031490) |
0.0 | 0.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
0.0 | 0.7 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.0 | 0.0 | GO:0033765 | steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
0.0 | 0.0 | GO:0046935 | 1-phosphatidylinositol-3-kinase regulator activity(GO:0046935) |
0.0 | 17.6 | GO:0008270 | zinc ion binding(GO:0008270) |
0.0 | 0.2 | GO:0016628 | oxidoreductase activity, acting on the CH-CH group of donors, NAD or NADP as acceptor(GO:0016628) |
0.0 | 0.0 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
0.0 | 0.3 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
0.0 | 0.0 | GO:0070996 | type 1 melanocortin receptor binding(GO:0070996) |
0.0 | 0.2 | GO:0030552 | cAMP binding(GO:0030552) |
0.0 | 0.1 | GO:0042393 | histone binding(GO:0042393) |
0.0 | 0.0 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
0.0 | 0.1 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.0 | 0.1 | GO:0003854 | 3-beta-hydroxy-delta5-steroid dehydrogenase activity(GO:0003854) |
0.0 | 0.0 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.0 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.0 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.0 | 2.0 | GO:0005125 | cytokine activity(GO:0005125) |
0.0 | 0.1 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.0 | 0.1 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.0 | 0.0 | GO:0003706 | obsolete ligand-regulated transcription factor activity(GO:0003706) |
0.0 | 0.0 | GO:0031491 | nucleosome binding(GO:0031491) |
0.0 | 0.2 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 2.8 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
0.1 | 1.2 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
0.1 | 1.5 | PID TCR JNK PATHWAY | JNK signaling in the CD4+ TCR pathway |
0.1 | 0.4 | PID SYNDECAN 2 PATHWAY | Syndecan-2-mediated signaling events |
0.1 | 1.7 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.1 | 1.6 | PID ALK1 PATHWAY | ALK1 signaling events |
0.1 | 0.4 | PID S1P S1P4 PATHWAY | S1P4 pathway |
0.1 | 0.7 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.1 | 4.4 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 1.3 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.1 | 4.2 | PID E2F PATHWAY | E2F transcription factor network |
0.1 | 1.3 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
0.1 | 0.4 | PID RET PATHWAY | Signaling events regulated by Ret tyrosine kinase |
0.1 | 2.0 | PID PLK1 PATHWAY | PLK1 signaling events |
0.1 | 0.7 | PID AVB3 OPN PATHWAY | Osteopontin-mediated events |
0.0 | 1.9 | PID HEDGEHOG GLI PATHWAY | Hedgehog signaling events mediated by Gli proteins |
0.0 | 1.0 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
0.0 | 1.1 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 1.3 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
0.0 | 0.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.0 | 0.7 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.0 | 1.7 | PID AR PATHWAY | Coregulation of Androgen receptor activity |
0.0 | 1.0 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.0 | 0.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.0 | 0.1 | SA G1 AND S PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
0.0 | 1.0 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
0.0 | 1.2 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.0 | 1.5 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.0 | 1.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.0 | 1.3 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.0 | 0.8 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.0 | 0.2 | PID MYC PATHWAY | C-MYC pathway |
0.0 | 0.6 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.0 | 1.0 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.0 | 0.1 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
0.0 | 1.0 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
0.0 | 0.1 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.0 | 0.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
0.0 | 0.4 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.0 | 0.2 | PID P38 ALPHA BETA PATHWAY | Regulation of p38-alpha and p38-beta |
0.0 | 0.2 | PID ARF 3PATHWAY | Arf1 pathway |
0.0 | 0.8 | PID P73PATHWAY | p73 transcription factor network |
0.0 | 0.4 | PID TELOMERASE PATHWAY | Regulation of Telomerase |
0.0 | 1.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.0 | 0.0 | SIG IL4RECEPTOR IN B LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
0.0 | 0.1 | ST STAT3 PATHWAY | STAT3 Pathway |
0.0 | 0.7 | PID ARF6 TRAFFICKING PATHWAY | Arf6 trafficking events |
0.0 | 0.4 | PID RB 1PATHWAY | Regulation of retinoblastoma protein |
0.0 | 0.0 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.0 | 0.0 | PID PDGFRA PATHWAY | PDGFR-alpha signaling pathway |
0.0 | 0.3 | PID BCR 5PATHWAY | BCR signaling pathway |
0.0 | 0.1 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.0 | 0.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
0.0 | 0.1 | PID BARD1 PATHWAY | BARD1 signaling events |
0.0 | 0.5 | PID NOTCH PATHWAY | Notch signaling pathway |
0.0 | 0.0 | PID HIV NEF PATHWAY | HIV-1 Nef: Negative effector of Fas and TNF-alpha |
0.0 | 0.2 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.0 | 0.3 | PID REG GR PATHWAY | Glucocorticoid receptor regulatory network |
0.0 | 0.3 | PID TAP63 PATHWAY | Validated transcriptional targets of TAp63 isoforms |
0.0 | 0.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
0.0 | 0.2 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.0 | 0.1 | PID ATM PATHWAY | ATM pathway |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.2 | 3.7 | REACTOME PROCESSIVE SYNTHESIS ON THE LAGGING STRAND | Genes involved in Processive synthesis on the lagging strand |
0.2 | 2.8 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.2 | 2.4 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
0.2 | 1.2 | REACTOME NEGATIVE REGULATION OF THE PI3K AKT NETWORK | Genes involved in Negative regulation of the PI3K/AKT network |
0.2 | 2.8 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.1 | 7.0 | REACTOME PACKAGING OF TELOMERE ENDS | Genes involved in Packaging Of Telomere Ends |
0.1 | 1.4 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.1 | 1.6 | REACTOME FORMATION OF ATP BY CHEMIOSMOTIC COUPLING | Genes involved in Formation of ATP by chemiosmotic coupling |
0.1 | 1.2 | REACTOME ALPHA LINOLENIC ACID ALA METABOLISM | Genes involved in alpha-linolenic acid (ALA) metabolism |
0.1 | 1.6 | REACTOME REGULATION OF IFNG SIGNALING | Genes involved in Regulation of IFNG signaling |
0.1 | 1.3 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.1 | 6.5 | REACTOME RESPIRATORY ELECTRON TRANSPORT | Genes involved in Respiratory electron transport |
0.1 | 0.6 | REACTOME PYRUVATE METABOLISM | Genes involved in Pyruvate metabolism |
0.1 | 1.5 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.1 | 1.5 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.1 | 0.3 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
0.1 | 1.0 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
0.1 | 1.4 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.1 | 0.6 | REACTOME ACETYLCHOLINE NEUROTRANSMITTER RELEASE CYCLE | Genes involved in Acetylcholine Neurotransmitter Release Cycle |
0.1 | 0.8 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 2.8 | REACTOME MRNA 3 END PROCESSING | Genes involved in mRNA 3'-end processing |
0.1 | 2.2 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.1 | 0.6 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
0.1 | 5.8 | REACTOME MRNA SPLICING | Genes involved in mRNA Splicing |
0.1 | 0.8 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.1 | 1.7 | REACTOME TGF BETA RECEPTOR SIGNALING ACTIVATES SMADS | Genes involved in TGF-beta receptor signaling activates SMADs |
0.1 | 0.4 | REACTOME GABA SYNTHESIS RELEASE REUPTAKE AND DEGRADATION | Genes involved in GABA synthesis, release, reuptake and degradation |
0.1 | 1.3 | REACTOME GPVI MEDIATED ACTIVATION CASCADE | Genes involved in GPVI-mediated activation cascade |
0.1 | 0.9 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.1 | 0.4 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.0 | REACTOME RNA POL III TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase III Transcription Termination |
0.1 | 0.9 | REACTOME TRAFFICKING OF GLUR2 CONTAINING AMPA RECEPTORS | Genes involved in Trafficking of GluR2-containing AMPA receptors |
0.1 | 0.6 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.2 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
0.1 | 1.0 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.1 | 1.2 | REACTOME REGULATION OF SIGNALING BY CBL | Genes involved in Regulation of signaling by CBL |
0.1 | 1.3 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.1 | 0.9 | REACTOME SYNTHESIS OF SUBSTRATES IN N GLYCAN BIOSYTHESIS | Genes involved in Synthesis of substrates in N-glycan biosythesis |
0.1 | 0.9 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
0.1 | 0.7 | REACTOME TRANSPORT OF ORGANIC ANIONS | Genes involved in Transport of organic anions |
0.1 | 1.6 | REACTOME PREFOLDIN MEDIATED TRANSFER OF SUBSTRATE TO CCT TRIC | Genes involved in Prefoldin mediated transfer of substrate to CCT/TriC |
0.1 | 0.3 | REACTOME POST CHAPERONIN TUBULIN FOLDING PATHWAY | Genes involved in Post-chaperonin tubulin folding pathway |
0.1 | 1.1 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
0.1 | 0.3 | REACTOME ERKS ARE INACTIVATED | Genes involved in ERKs are inactivated |
0.1 | 2.4 | REACTOME SCF BETA TRCP MEDIATED DEGRADATION OF EMI1 | Genes involved in SCF-beta-TrCP mediated degradation of Emi1 |
0.1 | 0.8 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.1 | 0.3 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.7 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.0 | 0.9 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.0 | 1.5 | REACTOME GLUCAGON TYPE LIGAND RECEPTORS | Genes involved in Glucagon-type ligand receptors |
0.0 | 0.6 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
0.0 | 0.3 | REACTOME ACTIVATION OF THE AP1 FAMILY OF TRANSCRIPTION FACTORS | Genes involved in Activation of the AP-1 family of transcription factors |
0.0 | 0.7 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.0 | 0.5 | REACTOME BASE EXCISION REPAIR | Genes involved in Base Excision Repair |
0.0 | 0.9 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.0 | 0.3 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.6 | REACTOME GENERATION OF SECOND MESSENGER MOLECULES | Genes involved in Generation of second messenger molecules |
0.0 | 0.8 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.0 | 0.9 | REACTOME EFFECTS OF PIP2 HYDROLYSIS | Genes involved in Effects of PIP2 hydrolysis |
0.0 | 2.4 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.0 | 0.6 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.0 | 0.7 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.7 | REACTOME CYTOSOLIC TRNA AMINOACYLATION | Genes involved in Cytosolic tRNA aminoacylation |
0.0 | 0.5 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
0.0 | 0.5 | REACTOME FANCONI ANEMIA PATHWAY | Genes involved in Fanconi Anemia pathway |
0.0 | 0.7 | REACTOME CHOLESTEROL BIOSYNTHESIS | Genes involved in Cholesterol biosynthesis |
0.0 | 0.9 | REACTOME STRIATED MUSCLE CONTRACTION | Genes involved in Striated Muscle Contraction |
0.0 | 0.3 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.0 | 2.4 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.0 | 0.8 | REACTOME INSULIN RECEPTOR RECYCLING | Genes involved in Insulin receptor recycling |
0.0 | 0.3 | REACTOME OPSINS | Genes involved in Opsins |
0.0 | 0.3 | REACTOME SCFSKP2 MEDIATED DEGRADATION OF P27 P21 | Genes involved in SCF(Skp2)-mediated degradation of p27/p21 |
0.0 | 0.4 | REACTOME PIP3 ACTIVATES AKT SIGNALING | Genes involved in PIP3 activates AKT signaling |
0.0 | 0.3 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
0.0 | 1.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.5 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
0.0 | 0.8 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.0 | 0.0 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.0 | 0.5 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.0 | 0.5 | REACTOME LATE PHASE OF HIV LIFE CYCLE | Genes involved in Late Phase of HIV Life Cycle |
0.0 | 0.9 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
0.0 | 0.4 | REACTOME BIOSYNTHESIS OF THE N GLYCAN PRECURSOR DOLICHOL LIPID LINKED OLIGOSACCHARIDE LLO AND TRANSFER TO A NASCENT PROTEIN | Genes involved in Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, LLO) and transfer to a nascent protein |
0.0 | 1.2 | REACTOME FORMATION OF THE TERNARY COMPLEX AND SUBSEQUENTLY THE 43S COMPLEX | Genes involved in Formation of the ternary complex, and subsequently, the 43S complex |
0.0 | 0.5 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 0.0 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
0.0 | 0.5 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
0.0 | 0.2 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.5 | REACTOME ACTIVATED NOTCH1 TRANSMITS SIGNAL TO THE NUCLEUS | Genes involved in Activated NOTCH1 Transmits Signal to the Nucleus |
0.0 | 0.1 | REACTOME DOWNREGULATION OF ERBB2 ERBB3 SIGNALING | Genes involved in Downregulation of ERBB2:ERBB3 signaling |
0.0 | 0.7 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.0 | 1.0 | REACTOME NUCLEAR RECEPTOR TRANSCRIPTION PATHWAY | Genes involved in Nuclear Receptor transcription pathway |
0.0 | 3.0 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.0 | 1.8 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
0.0 | 0.2 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
0.0 | 0.3 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
0.0 | 0.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.0 | 0.2 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 0.2 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
0.0 | 1.0 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.0 | 0.2 | REACTOME VITAMIN B5 PANTOTHENATE METABOLISM | Genes involved in Vitamin B5 (pantothenate) metabolism |
0.0 | 0.0 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
0.0 | 0.7 | REACTOME AMINE LIGAND BINDING RECEPTORS | Genes involved in Amine ligand-binding receptors |
0.0 | 0.2 | REACTOME NEGATIVE REGULATORS OF RIG I MDA5 SIGNALING | Genes involved in Negative regulators of RIG-I/MDA5 signaling |
0.0 | 0.8 | REACTOME APOPTOTIC EXECUTION PHASE | Genes involved in Apoptotic execution phase |
0.0 | 0.3 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 0.2 | REACTOME NEPHRIN INTERACTIONS | Genes involved in Nephrin interactions |
0.0 | 0.1 | REACTOME RNA POL I TRANSCRIPTION INITIATION | Genes involved in RNA Polymerase I Transcription Initiation |
0.0 | 0.1 | REACTOME ELEVATION OF CYTOSOLIC CA2 LEVELS | Genes involved in Elevation of cytosolic Ca2+ levels |
0.0 | 0.8 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 0.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.0 | 0.2 | REACTOME G1 PHASE | Genes involved in G1 Phase |
0.0 | 0.1 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
0.0 | 0.2 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
0.0 | 0.2 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
0.0 | 0.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
0.0 | 0.0 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
0.0 | 0.3 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
0.0 | 0.1 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.0 | 0.1 | REACTOME SEMA3A PAK DEPENDENT AXON REPULSION | Genes involved in Sema3A PAK dependent Axon repulsion |
0.0 | 0.2 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.2 | REACTOME HDL MEDIATED LIPID TRANSPORT | Genes involved in HDL-mediated lipid transport |
0.0 | 0.1 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
0.0 | 0.8 | REACTOME TRANSCRIPTIONAL REGULATION OF WHITE ADIPOCYTE DIFFERENTIATION | Genes involved in Transcriptional Regulation of White Adipocyte Differentiation |
0.0 | 0.3 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
0.0 | 0.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.0 | 0.4 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.0 | 0.0 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
0.0 | 0.0 | REACTOME SIGNALING BY ERBB2 | Genes involved in Signaling by ERBB2 |
0.0 | 0.1 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
0.0 | 0.1 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |